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SUMMARY
Levels of free SH groups are depressed in the sera of patients 
with rheumatoid arthritis (RA) especially during active 
disease. However, the immunopathological significance of this 
effect is uncertain. Using adjuvant arthritis (AA) as a model 
of RA, the changes in serum protein SH level and reactivity 
during the course of AA were studied using a 
spectrophotometric method. A major depression of serum SH 
level and reactivity was found in arthritic rats and this was 
associated with persistent inflammatory phase of disease. 
This depression may be caused by oxidative stress due to 
production of oxidative species by activated phagocytes. 
In vivo D-penicillamine treatment of AA rats increased both 
serum SH level of reactivity towards normal values over days 
14-21. This result suggests that D-pencillamine may act as a 
reducing agent, restoring the free SH groups that have been 
oxidised (blocked) in active AA.
Rat mononuclear cell proliferation to the mitogen ConA was 
stimulated by the addition of 2-mercaptoethanol (2-ME) to the 
cultures. This ConA response was completely inhibited by the 
cell surface SH blocking agent, PHMPSA. During the course of 
AA in Sprague-Dawley rats, spleen (SC) and lymph node cells 
(LNC) responded poorly in vitro to ConA. The addition of 2-ME 
was found to reverse and enhance this depressed ConA response. 
D-penicillamine in vivo also modified the pattern of ConA
stimulated proliferative response of AA rat SC and LNC, 
converting the markedly inhibited response to ConA at day 14 
to an enhanced response when compared with cultures from 
untreated arthritic rats and nonarthritic rats. These results 
indicate that cell surface thiols are necessary for the 
proliferation of rat SC and LNC and that the altered cell 
function in AA may be due, at least in part, to blockade of 
the functional free cell surface SH groups. 2-ME in vitro and 
D-penicillamine in vivo could help to maintain cell surface SH 
groups in a reduced state.
Alternatively, the depressed response could be attributed to 
suppression from activated macrophages via a mechanism 
involving SH groups. The depressed immune response in AA was 
not due to prostaglandin synthesis by activated macrophages 
nor was it due to an impaired synthesis of interleukins. 
Increased amounts of IL-1 were produced by AA rat peritoneal 
macrophages and SC from these animals produced slightly 
reduced amounts of IL-2. D-penicillamine treatment decreased 
the synthesis of IL-1 but had no effect on IL-2 production. 
The synthesis of these interleukins was not SH dependent as 2- 
ME and PHMPSA had no effect.
Although D-penicillamine treatment in vivo leads to dramatic 
changes in certain mononuclear cell (MNC) functions, it has no 
effect on the clinical course of AA. The significance of 
altered MNC activity in the pathogenesis of AA is therefore
XI
questionable and the usefulness of AA as a model for detecting 





The introduction to this thesis is divided into three parts, 
PART (I) describes the cellular interactions involved in the 
immune response. PART (II) deals with rheumatoid arthritis 
(RA) and the various experimental animal models of RA. A 
brief discussion of the chemotherapy of RA is also included. 
PART (III) deals with the role of SH groups in RA and its 
involvement in the immune system.
PART (I) THE IMMUNE RESPONSE
1-1 Cellular interactions in the immune response
In a broad sense, there are two types of specific immune 
response to antigen; (a) humoral immunity which results in 
specific antibody synthesis and secretion and (b) cell- 
mediated immunity which is associated with sensitised 
lymphocytes and their lymphokines.
Cellular immunity is normally regarded as a function of 
thymus-derived lymphocytes although non-specific accessory 
cells, probably macrophages (mĝ s) are also involved (Roitt et 
al., 1969). Humoral immunity to most antigens (T lymphocyte- 
dependent antigens) involves antigen specific T cell help 
being mediated to antigen specific B cells, by mç̂  (Roitt et 
al., 1969) and their secreted immunoregulatory soluble factors
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(Oppenheim and Gery, 1982).
It is now evident that a complex and intricate network of 
interactions occur between the two arms of immune response. 
These interactions can result in both amplification 
(enhancement) or suppression of immune reactivity.
This section will describe some of the interactions between T 
and B lymphocytes and macrophages resulting in humoral 
production of antibody and thus, without ignoring the 
importance of cell-mediated immunity, will concentrate on the 
humoral immune response to T-dependent antigens.
There are at least three types of cells involved in the immune 
response. Two of these cells are lymphocytic, morphologically 
indistinguishable and have been classified, on the basis of 
their site of differentiation, as thymus-derived (T cell) and 
bursa (birds) - or bone-marrow (mammals)-derived (B cell). 
The third cell type is phagocytic, often referred as an 
accessory cell and is thought to be mf6 (Herscowitz, 1979).
1.2 The cells involved in the humoral immune response
(a) B-lymphocytes
B-lymphocytes, the precursors of cells that synthesise 
antibody, are derived from the cloacal lymphoid organ, the
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Bursa of Fabric!us in birds (Moore and Owen, 1966). However, 
in mammals, B-lymphocytes are produced in a variety of major 
haemopoietic organs including foetal liver, foetal spleen and 
embryonic bone marrow (Owen, 1977). The definitive marker 
for B cells in both mice and humans is membrane surface 
immunoglobulin (sig). All mature human and murine B cells 
have easily detectable sIg. IgM and IgD are the main Ig 
classes present in the plasma membranes of mature B cells 
(Moller, 1977). In addition, human and murine B cells also 
bear cell surface receptors for the Fc portion of IgG (Dicker, 
1976) and for activated complement, C3 (Bianco and 
Nussenzweig, 1977) and express HLA-D and HLA-DR determinants 
in humans and H2, I-region (la) determinants in mice (Ferrone 
et al., 1978; McKenzie and Potter, 1979).
During the normal course of an immune response to most 
antigens, B cells produce specific antibody of the IgM class 
(the primary response) and on subsequent challenge with the 
same antigen, they will produce IgG class instead (the 
secondary response) (Roitt et al., 1981).
(b) T-lymphocytes
T lymphocytes are derived from the thymus. It is also at this 
site that the T cells become mature and "educated" to 
discriminate between "self" and "non-self" antigens 
(Zinkernagel et al., 1978). Those T cells which provide
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"help" for B cells specific for "self" components (and thus 
lead to auto immunity) will be eliminated (Howie, 1978).
Although T cells do not have readily detectable cell sig, all 
murine T cell express the Thy-1 determinant (McKenzie and 
Potter, 1979) and all human T cells have a plasma membrane 
receptor for sheep erythrocyte (SRBC) and will form rosettes 
when incubated with SRBC under appropriate in vitro conditions 
(Jondal et al., 1973).
As will be discussed later, subpopulations of human and murine 
T cells show differential expression of cell surface receptors 
for the Fc portion of IgG or IgM respectively (Moretta et al.,
1978). Subpopulations of murine T cells have also been 
defined by their differential expression of the Ly series of 
surface antigens coded by the major histocompatibility complex 
(MHO (Cantor and Boyse, 1977; McKenzie and Potter, 1979) and 
the presence of specific membrane la-determinants (McKenzie 
and Potter, 1979).
(c) The functional subsets of T lymphocytes in mice 
Helper T (TH) cells:
Helper T cells express Lyl"^23” surface phenotype, and 
generally lack I-associated (la) antigens. They are able to 
help B cells to proliferate and differentiate into antibody
- 5 -
secreting progeny (Miller, 1970). T cell help is most 
important in the IgG antibody response to low molecular weight 
protein antigens and to cell surface antigens. High molecular 
weight proteins or sugars with repeating antigenic 
determinants such as the LPS and bacterial flagella proteins 
are able to bypass the requirement for T cell help to induce 
antibody production directly (Coutinho and Moller, 1975). In 
humans, helper T cells possess an Fc receptor for IgM (Moretta 
et al., 1978) and react with certain monoclonal antibodies 
such as 0K-T4 (Reinherz and Schlossman, 1980).
Also included in the T cell subset are the T cells (TD cells) 
which involve in delayed-type hypersensitivity. These cells 
bear the same general surface characteristics as the helper T 
cells, i.e. LyT+23~ but they are usually Ia“. Activated TD 
cells will secrete humoral factors (lymphokines) which are 
important in cell-mediated immunity (David and David, 1972; 
Waksman and Namby, 1976).
Cytotoxic T (Tc) cells
Tc cells express Lyl“23'*' surface phenotype and are usually la"*" 
when activated. They can directly lyse allogeneic target 
cells in the absence of specific antibody or complement 
(Cantor and Boyse, 1975). In humans, Tc cells react with 
monoclonal antibodies 0K-T5 and 8 (Reinherz and Schlossman, 
1980).
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T suppressor (Ts) cells
Ts cells also express Lyl”23‘̂ surface phenotype but bear an 
la-determinant coded by the I-J region of MHC. This antigen 
[la"*” coded by (I-J)] is not expressed on TH, Tc or B cells and 
appears to be a unique marker for Ts cells (Miller, 1980).
Ts can regulate or suppress a variety of immunological 
reactions (Gershon, 1974; Moller, 1975). They have a function 
opposite that of TH cells. Ts cells can inhibit the 
triggering of B cells and other T cells functions - they serve 
to suppress the immune responses to specific antigens 
(Gershon, 1974).
There are also some T cells (Tf) which are responsible for 
feedback suppression and express both Lyl and Ly23 antigens in 
addition to the surface component Qal coded by an MHC gene 
mapping between H2-D and Tla (Miller, 1980).
In humans, Ts cells bear an Fc receptor for IgG (Moretta et 
al., 1978) and react with anti lymphocyte antibodies present in 
the sera of patients with active juvenile chronic 
polyarthritis (Strelkauskas et al., 1978 a,b) and monoclonal 
antibodies, 0K-T5 and T8 (Strelkauskas et al., 1978 a,b).
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(d) Macrophage (Mg$) accessory cells
The m^s are cells of the monocyte-leucocyte lineage with a 
generalised tissue distribution, e.g. they are present in the 
liver (Kuffler cells), lung (pulmonary alveolar mgfs), 
connective tissue (histiocytes), bone (osteoclasts), spleen, 
lymph node and bone-marrow (Nelson, 1976). The mĝ s bear 
plasma membrane receptors for the Fc portion of IgG (IgG^ and 
IgGg), C3b, macrophage chemotactic factors, lymphokines such 
as macrophage inhibiting factor (MIF) and several hormones 
including insulin and calcitonin (Zuckerman and Douglas,
1979). Mg$s express cell surface HLA-D and HLA-DR antigens in 
humans and la determinants in the mouse (Ferrone et al., 
1978).
Mĝ s play a crucial role in antigen processing, antigen 
presentation and cell-cell interactions in the immune 
response. Most in vitro assays associated with the immune 
functions of T and/or B cells required the presence of m^s 
(Roelants, 1977).
MgSs are required to process antigen and present it in a highly 
immunologic form to B cells (Unanue, 1972), in the generation 
of an antibody response to T-dependent antigens and for 
induction of most T cell-mediated immune responses, including 
the in vitro generation of cytotoxic cells, in vitro 
production of certain lymphokines, and in vitro blastogénie
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response to soluble antigens and mitogens such as PHA and ConA 
(Moller, 1978).
Although M^s play a crucial role in the complex series of 
cellular interactions leading to the generation and expression 
of immune responses their function is not antigen specific. 
Since mg( is not part of the antigen-specific network of 
reactive lymphocytes it is regarded as an accessory cell 
(Lipsky and Kettman, 1982). Several members of the 
mononuclear phagocyte system have been shown to support 
mitogenic responses and function as antigen presenting cells. 
These include peripheral blood monocytes (Rosenberg and 
Lipsky, 1979), Kupffer cells of the liver (Lipsky and Rogoff,
1980), peritoneal mç̂ s (Rosenthal et al., 1976), splenic 
adherent cells (Cowing et al., 1978) and alveolar mç^s 
(Lipscomb et al., 1981). However, not all of these 
populations could express these accessory functions. Only 
cells which bear cell surface la antigens (Cowing et al., 
1978; Lipsky and Rogoff, 1980) could effectively act as 
accessory cells (Yamashita and Shevach, 1977). More recently, 
other cell types which bear the la antigens were also found to 
have an accessory role in immune responses. These include the 
Langerhans cells of the skin (Braathen and Thorsby, 1982), 
dendritic cells of the lymphoid organs (Steinman et al., 1980) 
and also endothelial cells or fibroblasts (Lipsky and Kettman, 
1982).
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Mf6 may also modify lymphocyte reactivity through the action of 
secreted immunoregulatory molecules, particularly interleukin- 
1 (lL-1). IL-1 is a protein or a family of closely-related 
proteins with, as Oppenheim and Gery (1982) put it, "a 
multiplicity of pleomorphic amplifying effects on 
immunological and inflammatory reactions." It has been shown 
to promote lymphocyte differentiation (Rosenberg and Lipsky,
1981) and even to affect a variety of nonlymphocyte target 
cells (Oppenheim and Gery, 1982). IL-1 will also facilitate 
the production of interleukin-2 (IL-2) by presumably Ly*** 
helper subpopulations (Smith et al., 1980). IL-2 is the 
mitogenic lymphokine that is ultimately responsible for the 
proliferation of T cells (Farrar et al., 1980b; Smith et al., 
1980) in the presence of a specific antigen.
1.3 Cellular interactions in the humoral immune response
The induction and expression of immunity requires the 
effective presentation of antigen at the surface of mç̂ s or 
similar cells (Unanue, 1972). This is particularly true in 
the case of mçf participation in the T cell -B cell 
collaboration in the production of antibodies to thymus (In­
dependent antigens.
The mechanisms by which mgJs enhance immune responses can be 
categorised into two parts. The first involves all the 
functions associated with antigens and antigen specificity
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i.e. antigen uptake, processing and presentation. The second 
involves the release of antigen non-specific soluble factors 
(Rosenstreich, 1981).
When antigen is taken up by m^s a great proportion of it is 
degraded by phagocytic digestion and rendered non immunogenic, 
while a small part of the antigen remains in the mç̂  in a 
nondegraded, immunogenic form (Unanue and Cerottini, 1970) in 
some form of association with the la antigens of the MHC.
The uptake of antigen by mg$ is followed by the presentation of 
this antigen to the immune lymphocytes to induce their 
activation. This event involves the direct contact of T 
lymphocytes and m^s and is dependent on the mç̂  surface la 
antigens and lymphocyte receptors (Rosenstreich, 1981).
How does reactive T cell recognise mç̂  la and antigen? One 
hypothesis is that T cells bear a dual receptor with separate 
recognition units for la and for antigens. When both 
receptors are complexed, T cell activation occurs. The second 
hypothesis is that a single T-cell receptor recognises a 
complex of mf6 la with antigen (Rosenstreich, 1981).
In order to achieve effective antigen presentation, the mgf 
containing an antigen will physically interact and bind 
specific T lymphocytes to form m^-T cell clusters. This 
antigen-specific mg$-T cell cluster formation is la dependent
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(since antigen-specific clusters do not occur unless the T 
cells and mç̂ s are la identical) (Ben-Sasson et al., 1977) and 
mutually stimulatory for both cell types (Moore et al., 1980; 
Powell et al., 1980).
Exposure to the appropriate combination of processed antigen 
and m^ surface la alone may not be sufficient to activate 
lymphocytes. Additional and essential signals in the form of 
soluble factors generated by mç̂ 's are required for the 
initiation of lymphocyte activation (Rosenstreich, 1981). Mg$s 
are known to secrete several immunoregulatory molecules, one 
of which being interleukin-1 (IL-1) (Gery et al., 1972; 
Oppenheim et al., 1979). IL-1 production appears to be a 
characteristic of mç̂ s that bear la antigens as well as those 
that do not (Lee et al., 1979) although it is not certain 
whether or not all mg(s can secrete IL-1 (Lipsky and Kettman, 
1982).
lL-1, originally termed Lymphocyte Activating Factor (LAF), is 
defined by its ability to enhance mitogen stimulated thymocyte 
proliferation (Gery et al., 1972). Although it is an antigen- 
nonspecific mediator, it serves as an essential activation 
signal in all T cell-dependent antigen-specific immune 
responses (Mizel and Ben-zu, 1980). IL-1 is able to induce 
the synthesis and secretion of the T cell-derived mitogenic 
lymphokine interleukin-2 (IL-2) which serves to amplify T cell 
blastogenesis (Farrar et al., 1980b; Smith et al., 1980). The
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stimulation of IL-2 synthesis by IL-1 is dependent on the 
presence of another activating signal, either a specific 
antigen or a polyclonal T cell mitogen such as PHA or ConA 
(Mizel, 1982). Although IL-1 is required for T cell 
proliferation, it does not appear to be necessary for T cell 
recognition of the immunologic moiety presented by mjz$ (Chu et 
al., 1984).
Besides having a range of lymphocyte-directed functions 
(Oppenheim and Gery, 1982) IL-1 also has effects on many cell 
functions associated with inflammatory responses. IL-1 
appears to be similar if not identical to endogenous pyrogen 
affecting cells in the hypothalamus to cause fever via PG 
function (Murphy et al., 1980) and as serum amyloid (SAA)- 
inducer to stimulate hepatocytes to produce SAA and other 
acute phase proteins (McAdam and Dinarello, 1980). It also 
stimulates collagenase and prostaglandins production by 
rheumatoid synovial cells (Mizel et al., 1981) and promotes 
fibroblast proliferation in vitro (Schmidt et al., 1981). It 
may also induce degradation of matrix proteoglycan and 
collagen by activating chrondrocytes (Jasin and Dingle, 1981). 
Thus, IL-1 may permit mjz$ to regulate, in a concerted fashion, 
the in vivo activities of a variety of cell types that are 
involved in immunological and inflammatory responses (Mizel, 
1982).
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As stated above, IL-2 functions to provide the stimulus 
(signal) necessary for T cell proliferation. Once the 
activating signal has been received, IL-2 responsive cells 
will proliferate indefinitely solely in the presence of IL-2 
(Smith et al., 1979b). The acquisition of the IL-2 responsive 
state appears to be mediated by the appearance of IL-2- 
specific membrane binding sites (i.e. Tac) on appropriately 
activated cells (Smith et al., 1979b). The activated T cells 
and all the subsequent daughter cells continue to express IL-
2-specific responsiveness. This unique feature of T cells has 
allowed the creation of continuous long-term T cell lines 
(Smith et al., 1979b).
T cells from all three functional T cell subsets (i.e. 
cytotoxic, helper and suppressor) have now been shown to be 
capable of proliferating in response to IL-2 (Baker et al., 
1979; Schreirer et al., 1980; and MacDonald et al., 1980). 
However, of these three subsets, only T helper cells have been 
found to both produce and respond to IL-2 (Schreier, 1980).
In an antigen-induced antibody response, IL-2 will induce the 
proliferation of antigen-specific T helper cells by 
interacting with IL-2 receptor expressed on these cells 
(Lipkowitz et al., 1984). This interaction will spur the 
antigen-primed T helper lymphocytes to enter DNA synthesis and 
undergo clonal expansion (Oppenheim and Gery, 1982). The 
clonal replication of helper T cells will probably generate
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certain helper factors (Tada and Hayakawa, 1980) to trigger B 
lymphocyte activation and antibody production.
Since IL-1 has been shown to play a role in the generation of 
helper T cells (Farrar and Koopman, 1979) it is quite likely 
that IL-1 is acting in part via induction of IL-2 to increase 
the frequency of helper T cells (Watson, 1979). However other 
studies have argued that IL-1 may also directly affect B cells 
by promoting the differentiation of B cells and thus increase 
the frequency of B cells that are capable of responding to 
helper T cells (Wood, 1979; Hoffman et al., 1980). Hence, it 
is possible that IL-1 drives the helper T cells (and perhaps 
the B cells) to a partially activated state that is moved to 
completion in the presence of IL-2 (Mizel, 1982).
The cellular interactions associated with the humoral antibody 
response are subject to various control mechanisms which will 
regulate or suppress the magnitude of the immune response and 
the level of antibody synthesis. These control mechanisms may 
be mediated by the suppressor T cells, the idiotypic network 
and the hyperactivated mg(.
Suppressor T cells may exert negative feedback control on 
helper T cells (Cantor and Gershon, 1979) probably via, 
certain soluble antigen-specific I-J positive suppressor 
factors (Taniguchi and Miller, 1978). In humans, suppressor T 
cells have been found to depress T cell proliferation (Shou et
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al., 1976); and block immunoglobulin synthesis by B cells 
(Gupta et al., 1979). Specific antibody, after binding to 
antigen, will switch off B cell activity via FC-mediated 
mechanisms (Taylor, 1982). These may affect the B cell 
directly (Kolsch et al., 1980) or interfere with the T-B cell 
co-operation (Hoffman, 1980). The clonal replication of 
antigen-specific T cells and the production of specific 
antibody will cause increases in the expression of certain 
idiotypes and will disturb the "network" leading to the 
suppression of the response (Roitt et al., 1981).
suppression may involve several different mechanisms. Ptak 
et al. (1977) have demonstrated that mf6 membranes will block 
immune responses in vivo by binding the necessary growth 
factors required for lymphocyte activation. Activated mg$ may 
modulate immune responses via secreted prostaglandins. 
In vivo, exogenous prostaglandins will decrease antibody 
formation and in vitro they will depress antigen- and mitogen- 
induced lymphocyte stimulation (Rosenstreich, 1981).
Oxidative metabolites such as hydrogen peroxide, su peroxide 
anion, and hydroxyl radical, produced by activated m^, may 
have immunoregulatory consequences. This is based on the 
finding that reduced glutathione (GSH) will remove the 
continually generated deleterious oxygen intermediates that 
are harmful to the survival of lymphocytes in vitro (Hoffeld 
and Oppenheim, 1980). Indeed, hydrogen peroxide, for
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instance, has been found to suppress lymphocyte activity 
(Hoffeld et al., 1981) including the suppressor cells (Zoschke 
et al., 1982), but may, in other assay systems, be found 
necessary for lymphocyte activation (Novogrodsky et al.,
1982).
Hence, cellular interactions are necessary for the activation 
and regulation of clonal expansion of an immune response. The 
immune system appears to be constantly adjusting through 
negative and positive feedback mechanisms to 'self* and 'non­
self' antigens. Increasing appreciation of the complexity of 
immunoregulation has brought with it the awareness of the 
potential defects in this system.
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Part (II) RHEUMATOID ARTHRITIS AND THE EXPERIMENTAL MODELS OF 
RHEUMATOID ARTHRITIS
(A) The aetiology and immunopathogenesis of rheumatoid 
arthritis
1.1 Rheumatoid Arthritis
Rheumatoid Arthritis (RA) is "a subacute or chronic, non­
suppurative, inflammatory polyarthritis affecting mainly the 
peripheral synovial joints, normally in a symmetrical fashion, 
running a prolonged course of exacerbation and remission, and 
accompanied by signs of systemic disturbance such as anaemia, 
weight loss, and a raised erythrocyte sedimentation rate" 
(Duthie, 1969). Articular involvement is manifested 
clinically by pain, stiffness, limitation of motion, and signs 
of inflammation, i.e., swelling, heat, erythema and 
tenderness. Extraarticular features include rheumatoid 
nodules, arteritis, neuropathy, scleritis, pericarditis, 
lymphadenopathy and splenomegaly (Zvaif1er, 1979a).
1.2 Aetiology
The aetiology of RA is unknown. Indeed, it is not clear 
whether RA is one disease with multiple aetiologies or a 
symptom complex produced by a single causative factora
(Zvaifler, 1979). To date, however, attention has been 
A
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focused on two hypotheses, the role of microbial infection and 
the genetic predisposition to the disease.
The occurrence of polyarthritis during many human bacterial 
and viral diseases and the resemblance of RA to certain 
illnesses in animals caused by microorganisms make infection 
an attractive hypothesis (Pearson, 1979). However, despite 
intensive study, evidence implicating a specific infective 
agent in RA is still lacking. For example, direct approaches 
to the problem involving viral identification by electron 
microscopy, attempts to isolate viruses and microbes by 
culture of synovial fluid and membrane, or a combination of 
both (Denman, 1975; Dourmashkin et al., 1976) have met with 
little success. Attempts to rescue viruses by co-cultivation 
or DNA or RNA hybridization have also failed (Zvaifler, 
1979a). Recently, there has been increasing interest in the 
possible role of Epstein-Barr virus (EBV), a herpes virus, 
based on the high prevalence in RA sera of circulating 
antibodies to a nuclear antigen (RANA) present in EBV- 
transformed Wil2 human lymphoblastoid cell lines (Alspaugh et 
al., 1978). Whether this signifies a primary aetiological 
role for EBV infection in RA or a phenomenon secondary to the 
disease may be decided by investigation of patients with very 
early disease (Roitt, 198̂ ).
The interest in the role of genetic factors in the 
aetiopathogenesis of rheumatic diseases is generated through
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the work of Brewerton et al., (1973), who demonstrated a 
strong association between ankylosing spondylitis and the 
presence of histocompatibility antigen, HLA-B27. A relatively 
high risk of predisposition to RA has been found in HLA-DR4 + 
compared to HLA-DR4- individuals (Panayi et al., 1976; 
Stastny, 1978). However, Jones et al. (1983) suggested that 
HLA-DR4 is a marker of disease severity in RA rather than of 
susceptibility to arthritis.
Hence, it appears that RA may be due to the exposure of 
individuals with a particular genetic constitution to an 
infectious agent. The illness may result from an 
inappropriate immune response to a ubiquitous agent or 
conversely, the individual who develops RA may be less able to 
withstand infection by an uncommon pathogen (Zvaifler, 1979a).
1.3 The immunopathogenesis of RA
Although the underlying cause of RA remains obscure it is 
accepted that the debilitating damage that occurs in joints is 
directly connected with a local chronic immune associated 
inflammatory reaction (Zvaifler, 1973). An increasing number 
of observations suggest that both cellular and humoral 
immunological events mediate its pathogenesis. The presence 
in the synovial membrane of plasma cells, local production of 
immunoglobulins, the demonstration in the tissues and the 
circulation of rheumatoid factor and immune complexes together
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with the associated complement consumption in synovial fluid 
imply a role for humoral immune mechanisms (Smiley et al., 
1968; Zubler et al., 1976; Zvaifler, 1979a). In addition, the 
detection of lymphokines in rheumatoid synovial fluid (Stastny 
et al., 1975) and the high proportion of T lymphocytes in the 
synovial tissue (Duke et al., 1981) assert the importance of a 
hyperactive cell-mediated immune response. Also, the clinical 
observations of the therapeutic efficacy of cytotoxic 
(immunosuppressive) drugs in RA and lymphocyte depletion by 
thoracic duct drainage also support an immune pathogenesis of 
this disease (Pearson et al., 1979; Paulus et al., 1977).
Defects in the function of lymphocyte subpopulations may 
contribute to the pathogenesis of RA in any one of a few 
pathways involving the helper or suppressor role of T 
lymphocytes, leading to an inadequate response or to 
uncontrolled hyperresponsiveness respectively (Slavin and 
Strober, 1981). Indeed, cellular abnormalities in RA were 
shown to be predominantly within the T cell subpopulation 
(Bankhurst et al., 1976) as the lymphocytes extracted from the 
synovial fluids and synovial tissues of RA patients had been 
found to be predominantly of the T cell lineage (van Boxel and 
Paget, 1975; Abrahamsen et al., 1975). A mild degree of 
impaired T cell function in RA has been reported by many 
studies (reviewed by Hall and Bacon, 1981).
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Lymphocyte activation by PHA and ConA, but not PWM, was found 
to be depressed in a subgroup of RA patients with erosive 
joint disease (Silverman et al., 1976). This suggests 
deficiency in T cell function. Chattapadhyay et al., (1979) 
demonstrated the lack of suppressor cell activity from 
synovial tissue lymphocytes. Abdou et al. (1981) also 
demonstrated the suppressor T cell dysfunction and the 
presence of anti-suppressor cell antibody in the peripheral 
blood of active early RA patients but not in inactive RA and 
late active RA patients. The association of RA and Juvenile 
Rheumatoid arthritis (JRA) with features consistent with a 
disturbance of i mmunorégulâtion such as hypergamma- 
globulinaemia (Zvaifler, 1972) may also suggest suppressor T 
cell hypofunction as common variable hypogammaglobulinaemia is 
often associated with increased suppressor cell function 
(Waldman et al., 1974).
It has been demonstrated that rheumatoid synovial tissue and 
fluid contain activated T lymphocytes (Galili et al., 1981, 
Burmester et al., 1981; Janossy et al., 1981). HLA-DR or la 
antigen (from la-bearing m̂z$s or dendritic cells) appears to be 
the stimulus recognised by the T cells which subsequently 
becomes activated (Lattime et al., 1980). Surface marker 
studies of lymphocytes clustered around these HLA-DR+ m^-like 
(dendritic) cells in rheumatoid synovium indicate a 
preponderance of "helper" phenotype cells and a lack of 
"suppressor" cells (Duke et al., 1982; Klareskog et al..
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1982). This has led to a hypothesis that the pathogenesis of 
RA is the result of an imbalance of T lymphocyte/m<^ 
immunoregulatory mechanisms (Janossy et al., 1981).
Several lymphokines, including IL-2 macrophage migration 
inhibitory factor and mitogenic factor, have been detected in 
the fluid of inflamed joints from RA patients (Stastny et al., 
1975; Grout et al., 1976; Wilkins et al., 1983). Since 
lymphokines are known to induce the release of IL-1 from mf$s 
(Meltzer et al., 1977; Oppenheim et al., 1980) and since the 
synovium normally contains cells of the mononuclear phagocytic 
lineage including infiltrating monocytes (Zvaifler, 1973) it 
seems likely that IL-1 might also be present in the synovium. 
Indeed, IL-1 like factor has been isolated from most inflamed 
joint fluids including RA (Wood et al., 1983). If this IL-1 
like factor is indeed lL-1 then it might contribute to joint 
destruction. Potentially, IL-1 could stimulate the secretion 
of collagenase and prostaglandins (PG) from synoviocytes 
(Mizel et al., 1981). Collagenase would degrade the native 
collagen of the cartilage while PG would promote bone 
resorption and immediate events of inflammation (Wood, 1983).
Other alternative mechanisms that may contribute to the 
pathogenesis of RA include the immune response to collagen and 
the role of Epstein-Barr virus (EBV). The demonstration of 
antibodies directed to collagens in sera and synovial 
membranes of RA patients (Mestecky and Miller, 1975;
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Adriopoulos et al., 1976) suggested that collagen, acting as 
an autoantigen, may be involved in the initiation and/or 
perpetuation of a chronic inflammatory process.
Collagen-anticollagen immune complexes have been found in 
synovial fluid cells, presumably after phagocytosis (Steffen 
et al., 1974). Menzel et al. (1976) also reported the 
presence of such complexes and antibodies to denaturised human 
collagen in the synovial fluids of some patients of RA. A 
study of rheumatoid synovial membrane using 
tetramethylrhodamine isothiocynate-labelled collagens revealed 
prominent staining of plasma cells only with Type II collagen, 
indicating the production of antibodies to cartilage collagen 
(Mestecky and Miller, 1975).
It is still not clear whether an immune response to collagen 
is a primary event in the inflammatory process or whether the 
formation of anti-type II collagen antibodies is secondary to 
the pathological collagen degradation and exposure of antigen 
site on collagen peptides (Wager, 1976). It may be that the 
production of antibodies against collagen molecules with 
subsequent formation and phagocytosis of collagen-anticollagen 
immune complexes could mediate the pathological mechanisms of 
RA (Wager, 1976). Collagen-induced arthritis in rats will 
also be discussed later.
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Normal peripheral blood mononuclear cells when infected by 
EBV develop into lymphoblastoid cell lines which contain a "RA 
associated" nuclear antigen (RANA).
As mentioned earlier, most patients with RA have precipitating 
antibodies against this antigen (Alspaugh et al., 1978). It 
has been observed that RA lymphocytes form lymphoblast cell 
lines more readily than normal lymphocytes (Slaughter et al., 
1978). Also, Depper et al. (1979) found that rheumatoid 
peripheral blood mononuclear cells developed B lymphoblastoid 
colonies in a much shorter median time than normal peripheral 
blood mononuclear cells. This may be due to a deficiency of 
suppressor T cells capable of regulating or suppressing 
lymphoblastoid cell line formation in RA.
B. The Experimental Models of Rheumatoid Arthritis
Arthritis occurring in animals are mostly inherited dysplasias 
or infectious or degenerative diseases. Many are analogous to 
human arthritis. There are no ideal animal models for 
rheumatoid arthritis and most of the other rheumatoid diseases 
of obscure aetiology (Pearson, 1979). The lack of suitable 
animal models has hindered the search and the devising of good 
screening methods for truly effective anti-rheumatic drugs. 
Hence, one must use inadequate models to select usually 
inadequate drugs (Swingle, 1974). However, not entirely 
unsuccessful attempts have been made to devise animal models
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for the various rheumatoid diseases. In this part of the 
thesis only the experimental models of rheumatoid arthritis 
are discussed. An animal model may be considered to have two 
purposes:
(1) To verify or test the reasonableness of a theory 
concerning the aetiology of the disease under 
consideration.
(2) To allow manipulation of various factors which may 
exacerbate or ameliorate the pathological dysfunction 
under investigation (Whitehouse et al., 1974).
l.I Adjuvant Arthritis
Adjuvant arthritis (AA) has characteristically been considered 
to be a unique response of the rat to the appropriate 
combination of oil, heat-killed mycobacteria, and route of 
injection. This experimental disease has perhaps been the 
most extensively studied of all of the models of arthritis.
AA was first described by Stoerk et al. (1954) who observed 
polyarthritis in rats injected with a mixture of spleen 
homogenates and adjuvants. Later Pearson (1956) showed that 
complete Freund's adjuvant (CFA) was the one agent needed to 
induce this disease. AA can be induced only in rats. Species 
other than the rat are resistant to this disease and different 
strains of rats vary considerably in their susceptibility
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(Swingle, 1974). AA is commonly produced by a single 
injection of CFA containing mycobacteria into either the tail 
or the paw.
1.2 Method of induction
(a) Preparation of the adjuvant
Most commonly, heat-killed mycobacteria (e.g. M. butyricum, M. 
tuberculosis, or M. phei) are either suspended or emulsified 
in mineral oil or paraffin oil such that 0.2 - 1.0 mg. of the 
mycobacteria are contained in the injection volume (usually 
0.05 or 0.10 ml.) (Swingle, 1974). As high as 95 - 100% 
successful induction of the disease is attainable in most 
strains of rats if adjuvant is properly prepared, i.e. by 
grinding the mycobacteria in a mortar and pestle before 
preparing the suspension (Swingle, 1974).
Some other bacteria, bacterial cell walls or bacterial 
peptidoglycans can substitute for mycobacteria. Bacterial 
sources include Nocardia, Streptomyces, Staphylococcus, 
Streptococcus and Corynebacterium (Paronetto, 1970; Koga et 
al., 1973; Koga et al., 1976; Kohasi et al., 1977). The 
essential component appears to be a polymer of two or more 
disaccharides containing N-acetylglucosamine and N-acetyl 
muramic acid with a basic peptide unit (Kohasi et al., 1976b; 
Koga et al., 1979).
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Recently, Chang et al. (1980) observed that a synthetic, 
apparently non-immunogenic, low molecular weight compound, 
n,n-dioctadecy 1 -N^, -bis( 2-hydroxyethyl) propanediamine (CP- 
20961) can effectively substitute for peptidoglycan in 
Freund's adjuvant to induce AA. CP-20961, an interferon- 
inducer with antiviral activity (Hoffmann et al., 1973) was 
also shown to have adjuvanticity by enhancing the development 
of cell-mediated and humoral immune responses to the tumour 
cell line, EL4 in rats (Chang et al., 1980).
(b) Site and route of injection of the adjuvant
The intradermal route of injection is commonly used and is 
most effective when given in the foot pad or tail (Ward and 
Jones, 1962; Glenn and Gray, 1965). The volume and 
concentration of injected material are important. At least
0.1 mg. whole mycobacteria in a volume of 0.05 - 0.1 ml. is 
necessary to induce AA by foot pad or tail administration 
(Glenn and Gray, 1965).
(c) Experimental animals
Various strains of rats differ in their response to CFA (Glenn 
and Gray, 1965; Swingle et al., 1969). Lewis rats, when 
immunised with conventional CFA, were highly susceptible to 
AA, while Fisher and Buffalo rats were less susceptible 
(Swingle et al., 1969).
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The resistance to the disease in certain strains of rats is 
genetically dominant (Perlik and Zidek, 1973) and may prove to 
have an anatomical rather than a physiological basis. 
Whitehouse et al. (1973) have suggested that the apparent 
resistance of the Buffalo strain of rat is caused by the 
relatively poor lymphatic drainage of the site of injection of 
the adjuvant.
Both male and female rats develop AA (Swingle, 1974). 
However, AA is influenced by the age of the rat. Glenn and 
Gray (1965) found both young (< 21 days) and old (> 9 months) 
rats to be relatively resistant to the disease.
1.3 Clinical features and histopathology of adjuvant 
arthritis
Local injection of CFA results in an intense, transient, 
inflammatory response. Unlike RA, AA has a clear-cut starting 
point (the time of injection of CFA), followed by a well- 
defined latent period of 10 - 16 days (Pearson and Chang,
1977).
Usually, after about twelve days post-injection, arthritis and 
periarthritis suddenly appear in the extremities especially in 
the distal small joints of the paws. These are characterised 
by redness and swelling of varying severity and painfulness. 
The arthritis is often polyarticular and sometimes migratory
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(Pearson, 1979). The arthritis persists and intensifies 
during the 7-14 days after onset, then recedes over the 
ensuing weeks to months (Glenn and Gray, 1965). Erythematous 
nodules also develop over the tail, the external ears and the 
tip of the nose. An acute balanitis and urethritis is seen in 
some male rats. Occasionally, granulomas appear in the liver, 
spleen and lungs. Death rarely occurs from the disease except 
in the most severely affected animals (Pearson, 1979).
Histologically, the predominant early lesion is oedema and 
sparse mononuclear cell infiltrate. Within 2 or 3 days, 
intense synovitis with focal and diffuse accumulation of 
lymphocytes and mononuclear cells develops. A fibroblastic 
response leads to vascular granulation tissue involving bone. 
Pannus-like formations occur, and, in an intense osteoblastic 
reaction with periosteal new bone formation, results in 
ankylosis of joints (Pearson, 1979). Low grade synovitis and 
periarthritis with lymphocytic cellular infiltrate may persist 
for months (Burstein and Waksman, 1964). The ear lesions, 
balanitis and periarthritis all appear to be associated with 
perivasculitis (Pearson, 1979).
Considering the specie differences there are some remarkable 




Acute and recurrent arthritis ++ ++
Peripheral joints
Chronic deforming arthritis ++ ++
Eye lesions + +
Progressive and destructive
joint disease ++ ++
Pathological
Acute and subacute synovitis ++ ++
Primarily mononuclear cell
response ++ ++
Invasion of bone and joint
space by pannus ++ ++






Table X Comparison of AA and RA (from
Pearson, 1979)
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other laboratory findings of AA which resemble RA include 
anaemia, decreased serum iron, decreased rate of incorporation 
of iron into red cells (Mikolajew et al., 1969), and elevation 
of erythrocyte sedimentation rate, serum glycoproteins and 
copper (Gralla and Wiseman, 1968; Weimer et al., 1968). 
Rheumatoid factor and antinuclear antibodies, detected in RA, 
however, have not been reported in AA. Depressed levels of 
hepatic aminopyrine demethylase and of cytochrome P450, 
observed in RA, have also been reported in AA (Cawthorne et 
al., 1976) and may be associated with altered drug metabolism 
by the liver.
1.4 The Immunopathogenesis of adjuvant arthritis
Although the aetiology and pathogenesis of AA have not been 
established, the disease is believed to be due to an 
immunological process, possibly involving a delayed 
hypersensitivity reaction to disseminated antigenic 
constituents of the mycobacteria (Waksman et al., 1960) and/or 
an autoimmune reaction to homologous cell-bound antigen 
(Ryzewsky, 1967). The conclusion drawn from the early 
immunological studies that AA is primarily a disease of cell- 
mediated immunity (Waksman et al., 1960) was subsequently 
strengthened by numerous pharmacological studies showing that 
immunosuppressive drugs can prevent the development of 
adjuvant disease (Billingham and Davis, 1979). The failure to 
demonstrate either passive transfer of AA with serum (Waksman
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et al., 1960) or rheumatoid-factor production in AA rats (Katz 
and Piliero, 1969; Billingham and Davis, 1979) provided 
further evidence that in AA, unlike RA, antibody-mediated 
pathogenic mechanisms appear to play little or no role. 
Finally, passive transfer of the disease with lymph node 
(Waksman and Wennersten, 1963), spleen (Pearson and Wood, 
1964), or thoracic duct (Whitehouse et al., 1969) cells has 
been widely accepted as fairly conclusive for cell-mediated 
immune mechanisms as the key to pathogenesis of the disease.
There is also evidence that a certain T-cell subpopulation is 
involved in regulating the disease. Kayashima et al. (1976, 
1978) reported that procedures which remove suppressor cells,
i.e., low doses of cyclophosphamide, low doses of whole body 
irradiation, and adult thymectomy, enhance the arthritic 
process of AA when given before the administration of CFA. 
Furthermore, normal syngeneic thymocytes could abolish the 
enhancing effect of both low doses of cyclophosphamide and 
adult thymectomy. Wells and Battisto (1983) have demonstrated 
that AA can be suppressed by pre-treatment with several forms 
of altered syngeneic cells and suppression of AA is 
accompanied by a specific alteration in cellular immunity as 
shown by a decrease in the proliferative response to M. 
butyricum but not to a non-specific mitogen like ConA. They 
suggested that the decrease in proliferative and arthritogenic 
responses was attributable to induced suppressor cells.
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Studies on lymphocyte functions during AA by determining their 
ability to respond to various mitogens in vitro have suggested 
the involvement of T suppressor cells in AA. For example, the 
diminished responses of splenic lymphocytes to PHA and ConA in 
active AA are due to the presence of suppressor cells 
(Kourounakis and Kapusta, 1974).
Spleen cells from rat with active AA can also suppress the 
mitogenic responses of normal splenic lymphocytes implicating 
the existence of suppressor cells in AA (Kourounakis and 
Kapusta, 1974).
Gertzbein et al. (1979) also demonstrated a depressed response 
of adjuvant lymph node lymphocytes to PHA which the authors 
speculated to be due to inhibition by the suppressor factor 
released by a major subpopulation of pre-selected T suppressor 
cells by the arthritic process.
Piatier-Tonneau et al. (1982) found that there is a strain- 
dependent susceptibility to the induction of AA which is 
correlated with differences in T suppressor cells regulation. 
They showed that in the resistant Wistar A-G (WAG) rats, the 
in vitro response to the highly susceptible Lewis (LEW) rats' 
alloantigens was markedly inhibited 11 days after CFA 
injection, while LEW rats in vitro response to WAG 
alloantigens was increased slightly. Furthermore, WAG rats 
spleen cells 4 days post-inoculâtion exhibited T cell-mediated
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active suppression of the WAG in vitro response to LEW 
alloantigens when they were co-cultured with WAG normal spleen 
cells. This suppression was abolished by removal of T cells 
on nylon wool column or by irradiation of T cells. In 
contrast, T cells from CFA-treated LEW rats did not produce 
any effect on LEW in vitro response to WAG alloantigens. This 
suggests that the severe arthritis induced in LEW rats could 
be associated with defective suppressor cell functions, while 
in WAG rats CFA activated suppressor T cells could control the 
disease (Piatier-Tonneau et al., 1982).
Study by Tsukano et al. (1983) revealed that unresponsiveness 
to arthritogenic dose of CFA could be adoptively transferred 
by draining lymph node cells from rats rendered unresponsive 
by pre-treatment with subarthritogenic dose of the same 
adjuvant. These lymph node cells were probably T suppressor 
cells. These workers found that rats primed with subarthritic 
dose of CFA could elicit severe arthritis after reinoculation 
with non-mycobacterial synthetic adjuvant, suggesting that low 
dose induced unresponsiveness is antigen specific. These 
workers also suggested that the majority of the suppressor 
cells involved in the pathogenesis of AA in the low responder 
strain are non-specific naturally existing T cells (Kayashima 
et al., 1976, 1978), whereas those in high responder strain 
are antigen specific T cells.
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Binderup (1983a) showed that rats with AA have a decreased 
ConA-induced T suppressor cell activity in spleen cell 
suspensions 2 to 4 weeks after the induction of the disease. 
The development of defective T suppressor cell activity was 
positively correlated with the severity of the arthritic 
lesions. A marked impairment of T suppressor cell activity 
was observed in rats receiving a second booster injection of 
CFA, a treatment which may contribute to severe systemic 
changes of the disease. These results suggest that the rats 
with AA may fail to generate a normal level of T suppressor 
cell function on antigen stimulation and that this defect may 
give rise to the development and chronicity of the 
polyarthritic lesions (Binderup, 1983a). Several mechanisms 
were suggested by the same author to explain the decreased 
ConA-induced T suppressor cell activity in AA. Precursor T 
cells may be resistant to induction or decreased in relative 
number in the spleen cell suspensions. Other cell types (e.g. 
m^) may interfere with the normal induction of T-suppressor 
cells.
The function of mg(s was found to be altered during the course 
of AA (Binderup et al., 1980a,b). Suppressive m/z$s were found 
in the spleen and lymph nodes shortly after the induction of 
disease; these cells could inhibit the lymphocyte response to 
both T- and B-cell mitogens. Mf6 depletion with carbonyl iron 
particles prior to induction of disease resulted in 
restoration of suppressor cell activity to normal.
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Furthermore, lymphocytes from arthritic rats may release a 
soluble factor(s) that can activate macrophages to exert an 
inhibitory effect on the generation of T-suppressor cells, 
probably through the release of prostaglandins and/or other 
macrophage-derived mediators (Binderup, 1983b). 
Alternatively, the macrophages may exert a direct inhibitory 
effect on T precursor cells via cell-to-cell contact or via 
the release of soluble mediators (Binderup, 1983b).
Hence, the pathogenesis of AA seems to be not simply a cell- 
mediated response but rather the result of complex interaction 
of cell-mediated and humoral responses (MacKenzie et al., 
1978), more than one type of suppressor cells may be involved 
in the regulation of AA.
There is also accumulating evidence for a role of viruses in 
the pathogenesis of AA. Interferon (an anti-viral agent) 
inducing agents Statalon (Kapusta and Mendenson, 1967) pyran 
copolymer (Kapusta and Mendenson, 1969) and tilorone (Chang 
and Hoffman, 1977) can inhibit AA. Virazole, an anti-viral 
agent which does not induce synthesis of interferon, will also 
inhibit AA and reverse the appearance of suppressor cells 
(Kapusta et al., 1979).
However, the workers observed that Poly I:C (an interferon- 
inducer) has the ability to promote AA with MDP (Nagao and 
Tanaka, 1980) and the parainfluenza sendai virus which has
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been reported to suppress AA by prior infection but does not 
influence AA if the virus was given at or after the time of 
adjuvant injection (Garlington and Van Housier, 1978).
Hence, it may be that interferon, a known suppressor of both 
humoral and cell-mediated responses (Baron et al., 1979) 
exerts its effect through actions on lymphocytes and 
macrophages rather than via an antiviral action. Before more 
convincing evidence is gathered the viral aetiology of AA must 
remain speculative.
1.5 Antigen-induced Arthritis in rabbits
A chronic synovitis, closely resembles human RA with regard to 
histopathology and chronicity, can be produced in rabbits by 
an initial systemic immunisation followed by injection of the 
same antigen into a knee joint (Cooke and Jasin, 1972). This 
method of induction of arthritis is based on the earlier 
observations of Dumonde and Glynn (1962) on fibrin-induced 
arthritis. The ensuing antigen-induced arthritis (AIA) 
affecting the knee required the presence of in the initial 
immunisation, the development of delayed hypersensitivity, and 
high titre of circulating antibodies to the inducing antigen 
(Cosden et al., 1971). Ovalbumin (OVA) (Consden et al., 1971) 
and bovine serum albumin (BSA) (Cooke et al., 1972) have been 
the most extensively used antigens in this model of chronic 
inflammation. Besides rabbits, the disease can be induced in
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guinea-pigs (Dumonde et al., 1977), mice (Brackertz et al., 
1977a), and chickens (Oates et al., 1973).
Blackham et al. (1974) have reported that there is a 
genetically-related, strain-dependent, susceptibility to AIA 
among rabbits with joint swelling and histological lesions 
appearing in decreasing severity in Old English, New Zealand 
White, and Dutch rabbits. The AIA is chronic as judged by the 
presence of villous hyperplasia of the synovial membrane, 
pannus, lymphocyte and plasma cell infiltration and bone and 
cartilage erosions (Hunneyball et al., 1978). This immune 
synovitis can be significantly changed by altering the 
schedules for intraarticular challenge (Goldlust et al.,
1978).
The chronicity of the AIA might be explained by retention of 
antigen in the synovium. Glynn (1975) reported that some 
animals immunised and challenged with a single intraarticular 
injection still had active disease up to two years later. BSA 
or OVA used as the inducing antigen was specifically retained 
in the affected joints up to six times greater than that in 
control joints (Pearson, 1979). The injected antigen which 
subsequently binds to antibodies present in the synovial fluid 
produces immune complexes that become deposited on the 
articular tissues (predominantly articular cartilage, menisci, 
and ligaments) will result in the development of a type III 
hypersensitivity reaction to the antigen, after which T
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lymphocytes enter the joint, producing a type IV (delayed) 
hypersensitivity reaction. The chronicity of the arthritic 
response is dependent on the cell-mediated immune response toa
the /ntigen. Animals having circulating antibodies but no 
cell-mediated responsiveness produce only a transient 
inflammatory response lasting 30 days (Glynn, 1968). The 
persistence of AIA following a single articular injection has 
yet to be explained fully. The elimination of antigen from 
the joints of immunised rabbits is relatively slow and 
retained antigen may be responsible for persistence on the 
arthritis for up to 6 months (Consden et al., 1971). Hollister 
and Mannik (1974) found retention half-lives of antigen of 17 
days for ligaments, 31 days for articular cartilage, and 141 
days for meniscus, which suggests that small amounts of 
antigen may persist for longer periods of time, but this would 
still not explain persistence beyond 12 months. The most 
logical explanation comes from Glynn (1972), who suggested 
that the AIA pursues a biphasic course, with the first phase 
representing a hypersensitivity reaction to the antigen and 
the second phase representing a true autoimmune response. The 
demonstration of spleen cell responsiveness to collagen and 
proteoglycans in rabbits with chronic arthritis induced by 
intraarticular injection of Mycobacterium butyricum in 
preimmunised animals (Champion and Poole, 1980) lends support 
to this hypothesis.
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AIA in rabbits provides a model of arthritis that not only 
closely resembles RA at both macroscopic and histological 
level, its pattern of responsiveness to antirheumatic drugs is 
also very similar to that of RA. Hunneyball et al. (1979) 
have shown that prolonged daily oral treatment of rabbits with 
D-penicillamine (15-30 mg/Kg) beginning 16 weeks after the 
onset of chronic monoarticular arthritis, reduced the severity 
of chronic synovitis in a considerable proportion of animals. 
This was reflected in a reduction in joint circumference began 
40 to 50 days after initiation of treatment and this parallels 
the delay observed in rheumatoid patients between the 
initiation of treatment and onset of effect. When D - 
penicillamine treatment was initiated prior to immunisation, a 
greater reduction in joint swelling, histopathology, and 
macroscopic score was obtained (Hunneyball et al., 1979). The 
reduction in synovitis may be attributable to a suppression of 
the cell-mediated immune response to the antigen (Goldberg et 
al., 1974), or possibly to a stimulation of the phagocytic 
activity of macrophages (Hunneyball et al., 1979).
The limitations of AIA in rabbit with regard to its use for 
pharmalogical screening are mainly due to the size of the 
animal and the duration of treatment required to demonstrate 
activity with disease-modifying compounds, particularly those 
of the slow-acting type such as D-penicillamine. The 
development of a comparable model of arthritis in the mouse 
should minimise these problems, provided that it can be
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demonstrated that this model behaves in a similar manner to 
the clinical disease with regard to drug actions. However, 
both mouse and rabbit models suffer from the difficulty in 
continual assessment of the progress of the disease activity 
and, consequently, the actions of antirheumatic drugs 
(Hunneyball, 1984). The utility of these models for screening 
antiarthritic compounds will depend on the development of 
better methods of monitoring the disease process.
1.6 Collagen-induced Arthritis in rats
Immunological hypersensitivity to collagen may explain both 
the systemic nature and chronicity of inflammation in RA 
(Trentham et al., 1977). The demonstrations of antibodies to 
collagen in sera of patients with RA (Mestecky and Miller, 
1975; Adriopoulos et al., 1976) support this premise. For 
this reason, an experimental model of autoimmunity to 
collagen, i.e. collagen-induced arthritis (CIA) was studied. 
This inflammatory polyarthritis can be induced in rats by 
intradermal immunisation with native type II collagen in 
Freund's Adjuvant (complete or incomplete). The onset of 
arthritis normally occurs at 14 - 16 days postimmunisation 
with a peak onset at 20 days (Trentham et al., 1977). These 
authors showed that the incidence and severity of arthritis 
increased as the amount of collagen injected was increased. 
The clinical features of CIA were similar whether heterologous 
or homologous type II collagen was the immunogen or whether
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CFA or ICFA was used (Trentham et al., 1977).
The CIA in rats shares many similar features of human RA and 
AA in rats. Histopathologically, the primary lesion provoked 
by type II collagen is a chronic proliferative synovitis with 
intense mononuclear cell infiltrate of the synovial lining 
leading to erosion of the articular cartilage and subchondral 
bone. The invasion of mononuclear cells and their persistence 
in the synovium may suggest the importance of immune responses 
in the pathogenesis of this model (Trentham et al., 1977). 
Indeed, cellular and humoral immune responses to native type 
II collagen were found to be present in the rats after 
immunisation (Trentham et al., 1978; Stuart et al, 1979; 
Morgan et al., 1980). The arthritis can be transferred to 
native rats by cells (Trentham et al., 1978) or by antibody 
(gamma globulin fraction of serum taken from rats with CIA) 
(Stuart et al., 1982). Complement also appears to play a role 
in the initiation of this arthritis (Morgan et al., 1981).
The immune response towards type II collagen is under MHC (Ir- 
gene) control (Wolley et al., 1981) and only responder type 
animals appear to be susceptible to arthritis (Wolley et al., 
1981; Griffiths et al., 1981).
The development of CIA is dependent on functional T 
lymphocytes as the arthritis cannot be induced in nude rats 
(Klareskog et al., 1983). Using antibodies specific for la
— 43 —
antigens and different T cell subsets in the rats, Klareskog 
et al. (1983) demonstrated immunohistochemically that T cells, 
predominantly of "helper" type and anti-Ia-reactive non-T 
cells were abundant in the arthritic synovial tissue.
Firth et al. (1984) demonstrated that arthritic rats have 
higher levels of IgGl, IgG2a and IgG2b subclass antibodies to 
native bovine type II collagen than do non-arthritic rats 
although no IgG2c subclass antibodies could be detected in 
immunised animals. All four subclasses will activate the 
classical complement pathway and IgG2b will also activate the 
alternate pathway (Medgyesi et al.,1981). As a role for 
complement in CIA has been suggested by Morgan et al. (1981), 
these subclass antibodies may contribute to the pathogenesis 
of CIA via complement fixation. Also, the IgG2a subclass of 
serum antibody is known to participate in macrophage binding 
(Medgyeshi et al., 1981) and to mediate the cytotoxic effect 
of eosinophils (Capron et al., 1978). Hence, IgG2a, like IgE, 
when bound to antigen, will cause mast cell degranulation. In 
fact, the greatest difference between arthritic and non- 
arthritic rats was observed in the IgG2a subclass. Therefore, 
these cellular responses mediated by IgG2a may also contribute 
to the production of CIA (Firth et al., 1984). In addition, 
William et al. (1983) found that all rats which developed CIA 
had serum antibodies to native type II collagen, but not all 
responded to tests for cell-mediated immunity. These findings 
suggest that antibodies to collagen are more associated with
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the development of arthritis than is the cell-mediated immune 
response to collagen.
There are several reasons to believe that at least some of the 
pathogenic mechanisms that cause CIA are involved in human RA. 
This relationship has recently been reviewed (Stuart et al., 
1982; Trentham, 1982).
The most important similarity between CIA and RA is their 
mutual association with collagen immunity. Several workers 
have identified both cellular and humoral reaction to collagen 
in RA (Adriopoulos et al., 1976; Trentham et al., 1978; Stuart 
et al., 1980). This reactivity is linked to the MHC locus, 
specifically HLA-DR4 (Sollinger et al., 1981). However, one 
must interpret this data with caution since mouse strains that 
respond to collagen immunisation with high levels of collagen 
immunity but do not develop arthritis have been identified 
(Wolley et al., 1981). Another similarity between CIA and RA 
is the proliferative synovitis, marginal lesions, and 
cartilage destruction that characterises both diseases 
(Caulfield et al., 1982). However, there are differences 
between the animal model and RA. In CIA, periostitis is a 
prominent lesion that is not usually seen in RA. In RA, there 
are vasculitis changes in the synovial tissue that are not 
seen in CIA. The relevance of CIA as a model for predicting 
the effects of drugs effective in RA was determined by Sloboda 
et al. (1981) and Phadke et al. (1982) also found some
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correlations between the effects of nonsteroidal and steroidal 
anti-inflammatory drugs in CIA as compared to RA. D - 
penicillamine also has a beneficial effect that is reported to 
be similar to its effect in RA (Kerwar et al., 1981). Other 
antirheumatic drugs such as gold compounds (McCune et al., 
1980) and levamisole (Stuart et al., 1981) have no or minimal 
effect in CIA.
The CIA is a versatile system with several advantages over 
other animal models of arthritis. The use of a purified and 
biochemically characterised antigen, as well as the ability to 
induce disease in a reproducible manner, appears to suggest 
that further studies of CIA in rats may be helpful and 
fruitful.
(C) Chemotherapy in Rheumatoid Arthritis
1.1 Anti-inflammatory drugs
The anti-inflammatory agents in current use may be divided 
into non-steroidal anti-inflammatory drugs (NSAID) and 
steroids, and these will be discussed separately.
(a) Non-steroidal anti-inflammatory drugs (NSAID)
The NSAID can relieve pain and stiffness, reduce swelling and 
improve joint function, but they do little to reverse the
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underlying disease processes (Hart et al., 1982). NSAID such 
as aspirin, indomethacin, phenylalkanoid acids and others were 
first shown to inhibit prostaglandin (PG) synthesis by Vane 
(1971) and Smith and Willis (1971). Subsequent work from many 
laboratories has established that there is good correlation 
between the anti-inflammatory effects of nearly all classes of 
these drugs and their potency as PG synthesis inhibitors. The 
NSAID inhibit PG synthesis by a direct inhibition of the PG 
cyclooxygenase. All NSAID exhibit analgesic, anti-pyretic and 
anti-inflammatory actions as well as the characteristic 
gastrointestinal side effects. These toxic effects may be 
related to their common mechanisms of action. For example, 
PGs have been shown to inhibit gastric secretion in animals 
and man (Dilawari et al., 1973) and may have a protective 
effect on the gastric mucosa (Rainsford, 1982). Inhibition of 
these putative protective functions of PGs by the NSAID may 
explain some gastrointestinal toxicity. However, while 
clinical experience suggests, in general, that the NSAID are 
equally effective in patients, their potencies as 
cyclooxygenase inhibitors vary widely (Crook et al., 1976). 
Sodium salicylate, a less effective PG synthetase inhibitor, 
is clinically indistinguishable from aspirin. Also, 
cyclooxygenase activity in rheumatoid synovial tissue may be 
abolished in patients taking low doses of aspirin (600 
mg./day) which do not exert detectable anti-inflammatory 
effects. Aspirin irreversibly inhibits PGE2 synthesis of 
cultured human synovium, while other NSAID act reversibly
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(Crook et al., 1976). Thus it seems that although NSAID 
undoubtedly inhibit PG synthesis, this is not their sole 
mechanism of action.
Various NSAID have also been found to inhibit lysosomal enzyme 
secretion (Robinson, 1978; Smith and Iden, 1980) and 
superoxide anion production (Simchowitz et al., 1979; Smolen 
and Weissmann, 1980; Edelson et al., 1982) by human 
polymorphonuclear cells and guinea-pig mç̂  (Oyanagui, 1978). 
However, most of the above studies employed drug 
concentrations well in excess of physiological levels. More 
recently, NSAID have been shown to be sensitive inhibitors of 
chemiluminescence generated by H202-myeloperoxidase-Cl~ (Pekoe 
et al., 1982), the major cytotoxic system of neutrophils. 
Thus, it seems possible that part of the anti-inflammatory 
effect of NSAID is due to interference with the oxidative 
metabolism of neutrophils.
(b) Corticosteroids
Corticosteroids have numerous effects that probably contribute 
to their overall anti-inflammatory action. The drugs suppress 
the production and release of PGs (Lewis and Piper, 1975) by 
inhibiting phospholipase A2 and thus preventing the formation 
of arachidonic acid from membrane phospholipid. Phospholipase 
A2 inhibition is mediated by a protein, lipomodulin, the 
synthesis of which is induced by glucocorticoids (Hirata et
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al., 1980). In addition to the inhibition of PG synthesis, 
lipomodulin production has a number of anti-inflammatory 
consequences. Suppression of phospholipase A2 activity also 
prevents the formation of lipoxygenase products such as 
Leukotriene (LTB4) and interferes with the generation of 
Platelet Aggregating Factor (PAF). These effects on the 
production of the inflammatory mediators may help to explain 
the potency of steroids compared to NSAID. Corticosteroids 
also have effects on phagocytes especially monocytes. Steroid 
administration depresses monocyte bactericidal activity 
(Rinehart et al., 1975) and induces a profound monocytopaenia 
(Fauci et al., 1976).
The effects of glucocorticoids on the migration of various 
leucocyte populations may explain much of these drugs' anti­
inflammatory and immunosuppressive actions (Parillo and Fauci, 
1979). In addition to the monocytopaenia, bolus 
administration of hydrocortisone also causes a marked 
lymphocytopaenia with a selective loss of T cells (Fauci et 
al., 1976). This redistribution of mononuclear cells will 
prevent the accumulation of these cells in inflamed tissue and 
will thus exert a suppressive effect on the chronic 
inflammatory process.
1.2 Second-line antirheumatic agents
Most of the drugs in this category do not possess anti­
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inflammatory activity. Current thoughts on their modes of 
action revolve around modulation of the immune response, but 
it is very likely that each compound in this group has a 
different mechanism where it exerts its antirheumatic effect.
(a) Gold compounds
The rationale for chrysotherapy has its roots deep in 
empiricism. The first recorded use was in China around 
2500 B.C. (Walz, 1984). The basis of the early use of gold 
probably stems from folklore associated with precious metals. 
Forestier (1929) who reported positive results in patients 
with ankylosing spondylitis after treatment laid the 
cornerstone of modern chrysotherapy. Through the years, 
conflicting reports on the efficacy of gold compounds in the 
treatment of arthritis stimulated a number of controlled 
studies (Walz et al., 1974). The question of gold's efficacy 
was finally answered in 1956 when the Empire Rheumatism 
Council (ERC) (1961) conducted a well-controlled double-blind 
study with gold sodium thioraalate (GST) in a large patient 
population. The results from the study showed that, by 
practically all criteria, improvement was observed, the 
exception being improvement shown by X-ray examination. The 
beneficial effects of chrysotherapy persisted for more than a 
year even after therapy had been stopped. Sigler et al. 
(1974), in a double-blind study, confirmed the results of the 
ERC study and extended these findings. He described positive
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radiological evidence that chrysotherapy significantly slowed 
the progression of the disease in the joints of RA patients.
Although 5 decades of experience with gold compounds in the 
treatment of RA have clearly established their clinical 
efficacy (ERC, 1961; Marshall, 1965), their mode of action is 
still uncertain.
A variety of enzyme systems are influenced by gold, 
particularly those requiring free SH groups (Zvaif1er, 1979b). 
Gold inhibits several lysosomal enzymes in vitro (Persellin 
and Ziff, 1966; Ennis et al., 1968) and enzymes isolated from 
lysosomal fractions of m^s incubated with gold or hepatic 
lysosomes from gold-treated rats have diminished hydrolytic 
activity (Persellin and Ziff, 1966; Ennis et al., 1968). 
Addition of gold to tissue cultures of rheumatoid synovium and 
cartilage retards the rate of cartilage degradation (Hawkins 
et al., 1972), a process thought to be mediated by enzymes 
from synovial lysosomes.
In vitro the effects of gold compounds on the immune system 
have been investigated. Gerber (1974) has shown that the 
aggregation or dénaturation of IgG is reduced in the presence 
of pharmacological concentrations of gold sodium thiomalate, 
presumably because of its ability to stabilise disulphide 
interchange. Gold has the ability to reversibly inactivate 
the CIs component of complement in vitro (Schultz et al.,
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1974) and prevent the formation of C3 convertase by the 
alternative pathway (Burge et al., 1978).
In vitro responses of human peripheral blood lymphocytes to a 
variety of mitogens, tuberculin (PPD), and other lymphocytes 
in a mixed lymphocyte reaction were significantly inhibited by 
gold sodium thioglucose and thiomalate (Lies et al., 1977; 
Lipsky and Ziff, 1977). The latter authors have suggested 
that the inhibition of mitogen and antigen responses of normal 
human peripheral blood mononuclear cells is caused by the 
inhibition of monocyte accessory cell function and not by 
altering T cell function. (Sold compounds have also been shown 
to suppress PWM-induced antibody formation by inhibiting the 
requisite accessory cell function of monocytes (Lipsky, 1982).
Administration of gold sodium thiomalate to rats was shown to 
depress the phagocytic activity of mç̂ s in experimentally- 
induced inflammatory exudates and also to inhibit their 
capacity to migrate into sites of inflammation (Vernon-Roberts 
et al., 1973). Similarly, chrysotherapy diminished the 
augmented phagocytic capacity of blood monocytes from RA 
patients when tested in vivo by a modified skin-window 
technique although it had no effect on polymorphonuclear 
leucocyte phagocytosis (Jessop et al., 1973). In view of the 
critical role of m^s in both the induction and expression of 
immunologically-mediated inflammatory responses, interference 
with their function by gold compounds may well explain the
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efficacy of chrysotherapy in reducing rheumatoid inflammation
(Lipsky, 1982).
(b) D-penicillamine
D-penicillamine (D-pen) is a unique pharmacological agent in 
that it is used in treating many diverse clinical conditions. 
It is given for Wilson's disease due to its copper-chelating 
properties (Walshe, 1956). Since it forms a soluble mixed 
disulphide with cystine, it is used for treating cystinuria 
(Crawhall et al., 1963). D-pen was originally proposed for 
the treatment of RA because of its ability to dissociate 
macroglobulins (rheumatoid factors) by cleavage of their 
inter-subunit disulphide bonds (Deutch and Morton, 1957). 
However, Jaffe (1962) demonstrated that dissociation of 
rheumatoid factor (RF) only occurred following injection of 
penicillamine directly into the joints of RA patients and even 
then the effect was temporary. He also showed that prolonged 
administration of penicillamine could bring about a fall in RF 
(Jaffe, 1963) but later concluded (Jaffe, 1965) that this was 
unlikely to be due to simple splitting of the macroglobulins 
as it could not account for the time lapse between initiation 
of treatment and clinical effect.
The copper-chelating activity of D-pen exploited in the 
treatment of Wilson's disease may also play a role in the 
anti-rheumatic action of the drug. The resultant D-pen-copper
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complex has been shown to afford protection from superoxide 
radicals by expressing superoxide-dismutase-like activity 
although at a relatively high concentration (Greenwald, 1981). 
Moreover, the reactivity of penicillamine with native thiol 
compounds is not necessarily restricted to mixed disulphide 
formation with extracellular cysteine or indeed, with 
circulating macroglobulins like IgM. For the drug may also 
react with free SH groups in other proteins such as serum 
albumin, resulting in the displacement of bound low molecular 
weight compounds or in SH-dependent enzymes (Stanworth, 1984). 
Indeed, Hall and Gillan (1979) have shown that D-pen enhances 
SH-SS exchange reactions and Gerber (1978) also reported that 
D-pen inhibits the SH-dependent heat aggregation of IgG 
in vitro and might therefore prevent the formation of 
autogenic IgG aggregates in vivo.
D-pen treatment also reduced the raised level of a disulphide 
bonded complex between IgA and alpha-^-antitrypsin encountered 
in the serum and joint fluid of RA patients and this reduction 
is associated with clinical improvement (Stanworth, 1981). It 
has recently been shown that such complexes are capable of 
inhibiting phagocytosis by neutrophils, as well as promoting 
the release of acid hydrolases from m^s. These effects, if 
they occur in vivo, might contribute to the inflammation with 
the rheumatoid joints (Stanworth, 1984).
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Based on the clinical observations that D-pen therapy 
frequently results in lowered antiglobulin titres (Jaffe, 
1963; Multicentre Trial Group, 1973), decreased levels of 
circulating immune complexes (Epstein et al., 1979) and 
diminished levels of serum immunoglobulins (Bluestone and 
Goldberg, 1973; Epstein et al., 1979), Lipsky (1981) proposed 
that D-pen might exert an immunosuppressive action and inhibit 
the function of cells involved in humoral immune responses. 
D-pen, in the presence of copper, has been shown to inhibit 
the proliferative response of human peripheral blood T cells 
to nonspecific phytomitogens (Lipsky and Ziff, 1978). In 
these experiments, the T cell function appeared to be 
specifically inhibited while the monocyte accessory function 
was not affected. Later, these workers (1981) found that D- 
pen also inhibited the capacity of peripheral blood 
mononuclear cells to generate immunoglobulin-secreting cells 
in response to in vitro stimulation with T cell-dependent 
polyclonal B cell activators. Again, inhibition was observed 
only when cells were incubated with D-pen in the presence of 
copper ions. Other compounds, such as 2- 
mercaptoproprionyglycine and 5-thiopyridoxine also inhibited 
responsiveness in the presence of copper in this system 
(Lipsky and Ziff, 1981). The observation that pre-incubation 
with D-pen and copper ions did not alter the capacity of B 
cells to form immunoglobulin-secreting cells after appropriate 
stimulation, but rather diminished helper T cell activity, 
implies that the action of D-pen and other thiols results from
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a selective inhibition of T cell function (Lipsky, 1981).
McKeown et al. (1984) have shown, using pokeweed mitogen 
stimulated IgG synthesis as the assay system, that monocytes 
from patients with active RA are defective and normal cell 
function could be restored either by treating cells in vitro 
with 2-ME or by treating the patients with D-penicillamine - 
an indication that monocyte accessory function may be 
dependent on cell surface SH groups.
Binderup et al. (1978) showed that very low percentage of rat 
peritoneal m^s, pretreated with D-pen, markedly enhanced 
in vitro rat lymphocyte proliferation. In addition, in vivo 
D-pen treatments of rats results in an increase of in vitro 
DNA synthesis of unstimulated and stimulated lymphocytes 
(Binderup et al., 1980). Both studies suggest a modulating 
effect of mg(s on lymphocyte transformation, an effect itself 
modified by D-pen. Later, Arrigoni-Martelli and Binderup 
(1981) also reported that the suppressed response of lymph 
node lymphocytes in AA rats was caused by the inhibition by 
suppressive mç( activity - an inhibition that could be 
abolished by D-pen treatment which also enhanced T helper cell 
function.
Although the mode(s) of action of D-pen remains unclear, the 
importance of the SH moiety of the drug for its 
immunomodulating effects, actions that may be shared by other
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SH-reactive compounds (Jaffe, 1980) must be emphasised. The 
role of different SH groups in immunoregulation of autoimmune 
disease will be reviewed in the next section.
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PART (111) THE ROLE OF SH OtOOPS IN RHEOMATOID ARTHRITIS
1.1 Serum SH groups and reactivity in RA patients
Subnormal levels of serum sulphydryl (SH) groups have been 
observed in various connective tissue disorders including RA 
(Lorber et al., 1964). The depression of serum SH levels in 
RA correlates with active disease (Haataja, 1975). The 
erythrocyte membrane surface SH groups are also found to be 
deficient in RA and associate with the decrease in plasma 
protein SH levels (Lorber and Chang, 1968). The low levels of 
total serum SH in RA have been shown to increase towards 
normal with clinical improvement (Lorber et al., 1971) and 
with certain drug therapy, though early work suggested that 
they may alter with both antirheumatic drugs and some non­
steroidal anti-inflammatory drugs (Evans, 1975).
It has been suggested that the low thiol levels in RA may be 
associated with a disturbance of the sulphydryl-disulphide 
(SH-SS) exchange reaction that could lead to the aggregation 
of serum proteins, particularly IgG, with the exposure of new 
antigenic sites leading to autoantibody production (i.e. 
rheumatoid factor). As a model for this hypothesis Gerber 
(1964) has shown that heat-aggregation of IgG is partly thiol 
dependent and may be inhibited by SH compounds such as sodium 
aurothiomalate and D-penicillamine (Gerber, 1974).
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There are two distinct assay methods for thiols: the first 
measures the rate of SH-SS exchange reaction (reactivity), the 
second quantifies total serum sulphydryl. Gerber et al. 
(1967) have reported that a number of NSAIDs including large 
doses of aspirin, exhibit a high degree of specificity in 
accelerating the SH-SS interchange reaction between human sera 
and Ellman's reagent, 5,5*-dithiobis (2-nitrobenzoic acid) 
(DTNB). Oronsky et al. (1969) have shown that sulphydryl 
binding agents are capable of suppressing the inflammatory 
process and that the anti-inflammatory activity of these 
agents and certain NSAIDs is, at least partly, related to 
their effects on SH groups. Serum SH-SS interchange reactions 
are severely impaired in AA and may be restored by 
administration of anti-inflammatory agents (Butler et al., 
1969). However, Walz and Di Martino (1972) reported that the 
SH-reactive anti-arthritic drugs, sodium aurothiomalate and 
sodium aurothioglucose, produced a potent, dose-dependent 
inhibition of the SH-SS exchange reaction between rat serum 
and DTNB although the NSAIDs (phenylbutazone, indomethacin and 
aspirin) administered in vitro or in vivo, accelerated the 
interchange reaction in diluted rat serum.
In humans, three second-line antirheumatic drugs, namely 
aurothiomalate, D-penicillamine and levamisole, have been 
shown to stimulate serum protein SH reactions in vivo as 
measured by exchange with DTNB in vitro (Hall and Gillan, 
1979). High concentrations of indomethacin were also shown to
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stimulate the SH-SS exchange reaction between protein SH 
groups and DTNB in vitro (Hall and Gillan, 1979). These 
authors postulated that the mechanism whereby indomethacin 
stimulates protein SH reactivity towards DTNB differs from 
that of aurothiomalate, D-pencillamine and levamisole. The 
latter three compounds share the ability to interact directly 
with protein SH groups. Indomethacin and other NSAIDs are 
devoid of active SH groups and may stimulate thiol reactivity 
via an indirect or "allosteric" effect on protein conformation 
(Hall and Gillan, 1979). To lend support to this hypothesis, 
Hichens (1966) suggested that the increased rate of reaction 
associated with the NSAIDs may be indicative of free SH groups 
being uncovered by NSAIDs through an induced conformational 
change of the protein molecules. Human plasma has far more SS 
groups than SH groups. It contains little or no non-protein 
thiol and its protein SH concentration is about 0.4 - 0.6 mM 
(Lorber et al., 1970). Most of the SH groups reside in the 
serum albumin molecules. This protein has 17 cystine residues 
and a fractional SH of 0.65 - 0.68 per mole. The reason for 
the fractional SH titre of serum albumin is that a part of the 
protein has lost its free SH group in forming a mixed- 
disulphide with either a cysteine or to a lesser extent, 
glutathione (Jocelyn, 1972).
The phenomena of autooxidation and mixed-di sulphide formation 
may account for the depressed serum SH level in RA. Hall et 
al. (1984) have shown that the lowering of serum SH levels in
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RA may be due to oxidation caused by the release of hydrogen 
peroxide and oxidative intermediates from activated phagocytes 
(Badway and Karnovsky, 1980). Neutrophils generate relatively 
more hydrogen peroxide in vitro than do monocytes (Reiss and 
Roos, 1978). Thus, depressed serum SH content in early 
synovitis may be indicative of stimulated phagocytes, 
particularly neutrophils, liberating oxygen free radicals and 
other tissue damaging species (Hall et al., 1984). Since 
scavengers of superoxide anion and hydrogen peroxide are not 
easily detectable in rheumatoid serum or synovial fluid (Blake 
et al., 1983) these two reactive species may undergo an iron- 
catalysed reaction to produce hydroxyl radicals (Halliwell, 
1978) which may cause degradation of lipids (Donato, 1981) and 
hyaluronic acid (McCord, 1974). These reactions may 
contribute to the inflammatory events seen in the synovial 
tissue and fluid. This mechanism may explain the association 
between low serum SH in early RA (active phagocytes generating 
hydrogen peroxide etc.) and more aggressive RA (production of 
hydroxyl radicals and subsequent lipid peroxidation and tissue 
damage).
In addition, as RA is an inflammatory polyarthritis, plasma 
levels of caeruloplasmin, an acute phase reactant, are 
increased (Conforti et al., 1982). This protein can rapidly 
oxidise certain low molecular weight thiols to formed 
disulphides (Albergoni and Cassini, 1978). Although it does 
not affect the thiol of albumin directly, presumably due to
- 61 -
the steric hindrance between the two proteins, the disulphides 
formed with the low molecular weight thiols may interact via 
SH-SS exchange reaction with the SH groups present in albumin 
(Foster, 1977) and this may also contribute to the lowering of 
serum protein SH levels in active RA.
1.2 Sulphydryl involvement in the immune system
The protein SH groups, unless masked in some proteins, are 
chemically the most reactive groups found in cells (Jocelyn, 
1972) and participate in a wide range of biological processes 
(Jensen, 1959). More recently, many authors have reported 
that a variety of simple, low molecular weight thiol compounds 
augment various lymphocyte reactions in vitro (Click et al., 
1972; Broome and Jeng, 1973) and this implicates a role for SH 
groups in immunoregulation.
2-mercaptoethanol (2-ME), one of the most effective thiols, 
has been used extensively as an additive to culture media in a 
variety of tissue-culture systems (Metcalf, 1976). At optimal 
doses, it has been found to (1) enhance the DNA-synthetic 
response of both human and rabbit lymphocytes to mitogens 
(Fanger et al., 1970) and to allogeneic lymphocytes in murine 
mixed lymphocyte cultures (MLC) (Heber-Katz and Click, 1972; 
Bevan et al., 1974), (2) enhance the murine primary humoral 
antibody response in vitro (Click et al., 1972), (3) propagate 
murine lymphoma cell line in vitro (Broome and Jeng, 1973),
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(4) augment the generation of mouse cytotoxic thymus-dependent 
lymphocytes in the MLC (Cerottini et al., 1972; Engers et al.,
1975), (5) allow the culture and propagation of clones of
mouse B lymphocytes (Metcalf et al., 1975; Metcalf, 1976), (6) 
functionally replace mouse peritoneal macrophages in the 
primary humoral immune response (Chen and Hirsch, 1972) and 
(7) act as polyclonal activator of murine B cells (Goodman and 
Weigle, 1977) or cytotoxic T cells (Igarashi et al., 1977).
The stimulatory effect of 2-ME on the immune response in vitro 
was first described by Click et al. (1972). They showed that 
2-ME restored the antibody-forming capacity of adherent cell 
depleted spleens to that of the unfractionated cell 
population. This phenomenon was not due to promotion of cell 
viability because daily inclusion of 2-ME into the culture was 
not necessary (Click et al., 1972). 2-ME is readily oxidised 
in tissue culture media and its half-life under these 
conditions is 5.9 hours (Broome and Jeng, 1973). Hence, the 
reducing agent may exert its effect on a very early event of 
lymphocyte activation (Click et al., 1972). Also, kinetic 
studies have shown that the development of plaque-forming 
cells in cultures with 2-ME progressed at an exponential rate 
earlier and for longer periods than in cultures lacking the 
reducing agent (Click et al., 1972).
2-ME could augment the primary antibody response in vitro not 
only to SRBC (a thymus-dependent antigen) but also to TNP-
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Ficoll and TNP-LPS (thymus-independent antigens). It has been 
reported that mĵ s were necessary for antigen presentation to B 
cells to generate the immune response to TNP-Ficoll (Boswell 
et al., 1980a). However, the response to TNP-LPS requires 
neither mĵ s nor T cells (Boswell et al., 1980b). Ohmoshi and 
Yamamoto (1982) confirmed that depletion of either adherent 
cells or T cells from murine spleen cells did not affect the 
enhancement of the response to TNP-LPS by 2-ME. Therefore, B 
cells would be the target of 2-ME action, at least in this 
case. On the other hand, Chen and Hirsch (1972) and Lemke and 
Opitz (1976) have proposed that 2-ME can functionally 
substitute for m^s in the primary anti-SRBC response in vitro. 
They depleted the m^s from spleen cells by glass adherence 
(Chen and Hirsch, 1972) or by carbonyl iron treatment (Lemke 
and Opitz, 1976).
The above data have generated a question: Is the response of
T and B cells to SRBC in the presence of 2-ME truly m^ 
independent? Hodes and Singer (1977) have shown that the 
primary response to TNP-protein, following depletion of 
accessory cells by Sephadex G-10 columns, was strictly 
dependent on accessory cells. 2-ME, however, has no effect in 
this system. Other workers have also demonstrated that the 
response to SRBC (Ly and Mi shell, 1974) or TNP-Ficoll (Boswell 
et al., 1980a) was abrogated, even in the presence of 2-ME, 
when spleen cells were effectively depleted of adherent cells 
by passage through Sephadex G-10 columns. Furthermore,
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Rosenstreich and Mizel (1978) reported that 2-ME could not 
replace the need for m^s in the lectin-induced response, 
although it would enhance the activity of a very small number 
of miz$s added to the culture. These results indicate that 2-ME 
synergise with mç<s to increase the response. Ohmori and 
Yamamoto (1982) have also confirmed that 2-ME could not 
substitute for the function of m^s in the Sephadex G-10 
treated spleen cells. Hence, 2-ME could not totally replace 
the role of m^s, but rather a class of adherent cells which 
could not be removed by glass adherence or carbonyl iron 
treatment but could be depleted by Sephadex G-10 method might 
be involved in supporting the antibody response as accessory 
cells in the presence of 2-ME. However, it is also possible 
that in the presence of 2-ME, the antigen-presenting function 
may be performed by the B cell during its handling of Ag, 
particularly if these B cells are in high frequency, as in 
primed animals. This applies particularly to the SRBC 
response (Unanue, 1981).
The reducing activity of thiols in the culture medium was 
brief - a few hours (Broome and Jeng, 1973). Therefore, if 
the compounds acted directly on the lymphocyte, they should do 
it during the first few hours of culture. Chen and Hirsch 
(1972b), however, found that medium containing 10% foetal calf 
serum (FCS) treated with 2-ME retained its activity for 
promoting antibody formation for at least three days and 
suggested possible secondary effects. That the thiols might
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have direct effects was suggested by experiments in which 2-ME 
was added to cells in the absence of protein, but the optimal 
growth potential required the addition of serum to the media 
(Lemke and Opitz, 1976). Similar observations were made by 
Goodman and Weigle (1977) who found that 2-ME showed a weak 
mitogenic activity in serum-free culture, which was however, 
enhanced by about ten-fold under serum-containing conditions. 
They suggested that 2-ME is able to activate lymphocytes 
directly. However, Opitz et al. (1978) stressed that 2-ME 
does not stimulate the DNA synthetic response by highly 
purified T lymphocytes and elicits negligible responses in B- 
lymphocytes in serum-free medium. This suggests that 2-ME has 
actually no direct lymphocyte-activating properties. The same 
authors showed that preincubation of FCS with 10“  ̂- 10"^M 2- 
ME followed by removal of free 2-ME resulted in the conversion 
of a native serum factor (Pro-MaSF) in the FCS into the 
activated serum factor (MaSF) that could elicit the antibody 
response to SRBC (Lemke and Opitz, 1976) and anti-IgM-induced 
B cell proliferation (Sidman and Unanue, 1978) without further 
addition of 2-ME. Both Opitz et al. (1977) and Sidman and 
Unanue (1978) reported that 2-ME-activated serum factor(s) 
(i.e. MaSF) were eluted from Sephadex G-lOO column near 
albumin. Indeed, Hewlett (personal communication, 1981) 
postulated that pro-MaSF was albumin and MaSF mercaptalbumin. 
The addition of 2-ME and, presumably, m^s, reduced the albumin 
to mercaptalbumin, the active fraction for the induction of 
the immune response.
— 66 —
An alternative explanation for the effect of 2-ME on 
lymphocyte activity has been suggested by Ohmori and Yamamoto 
(1983b) who demonstrated that 2-ME-pulsed FCS can support the 
antibody response in the absence of additional 2-ME as 
effectively as native FCS in the presence of 2-ME. They 
postulated that the supporting activity of the antibody 
response in 2-ME-pulsed FCS was due to 2-ME molecules bound to 
FCS components via disulphide bonds. The thiol groups on the 
FCS components do not appear to exert the supporting effect of 
FCS but they would serve as a repository for 2-ME to maintain 
the appropriate 2-ME concentration in the culture medium to 
augment the antibody response (Ohmori and Yamamoto (1983b).
These authors also suggested that a major role of 2-ME in the 
augmentation of antibody response would be to stimulate the 
utilisation of cystine in both B cells and T cells through the 
formation of Cys-2-ME and that the 2-ME transformed into F(ZS- 
bound and oxidised forms could be used for the formation of 
Cys-2-ME via interaction with the lymphocytes.
However, other workers have shown that activation of 
lymphocyte reactions may be mediated via an alteration in cell 
surface SH groups. Chaplin and Wedner (1978) have reported 
that blockade of free SH groups on human peripheral blood 
lymphocyte cell surface by diamide and other sulphydryl 
reagents leads to an inhibition of lectin-induced lymphocyte 
activation, and that the inhibition is not due to decreased
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intracellular levels of reduced glutathione or inhibition of 
binding of lectin to the lymphocyte. They suggested that the 
maintenance of free SH groups is important during the early 
induction of lymphocyte proliferation. Later, Wedner and 
Wilson (1983) demonstrated that when human peripheral blood T 
lymphocytes were incubated with ConA or PHA, washed and 
incubated with 5-iodacetamide salacylic acid (5-ISA), 5- 
maleimidyl salacylic acid (5-MSA) and assayed as cell 
suspensions or smeared on microscope slides, incubated with 3- 
maleimidyl-phenyl coumarin, and assayed using a microscope 
photometer, lymphocytes incubated with ConA or PHA showed a 
marked increase (peaked at 30-45 minutes) in free SH groups 
compared to control. The increase returned to baseline by 60 
minutes. Lymphocytes depleted of glutathione had 
significantly more free SH, and peak increase seen with PHA or 
ConA was 15 minutes and decayed below control levels by 45 
minutes. Since 5-MSA and 5-ISA are impenetrant this result 
suggests that lymphocyte activation is accompanied by rapid 
alterations in free SH groups located in or near the plasma 
membrane. The change in SH may involve proten-glutathione 
di sulphide exchange reactions. These exchange reactions may 
be crucial stages in the early events leading to lymphocyte 
activation (Wedner and Wilson, 1983). In addition, Noelle and 
Lawrence (1981) have also demonstrated that oxidation of 
lymphocyte cell-surface thiol groups can ablate the ConA- 
induced response, and that this oxidative inhibition by O2 or 
by the impermeant oxidant copper-phenanthroline could be
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completely reversed by 2-ME.
In a study of the functional correlates of molecular structure 
of thiol compounds, Goodman and Weigle (1981) compared 2-ME 
with ethanol (lacking the SH group of 2-ME) and with 
ethanethiol (lacking the OH group of 2-ME) in culture when 
added either singly or conjointly. They showed that neither 
analogue was mitogenic and that only ethanethiol had a weak 
ad juvanticity. Thus, both the SH and hydroxyl groups had to 
be present on the same molecule to produce mitogenic and 
adjuvant activity. These results suggest that the SH group 
would play a major role in the augmenting effects of 2-ME on 
both the proliferative and the antibody responses while the 
hydroxyl group may contribute to make the compound nonvolatile 
and modify the interaction of the thiol group with the cells 
(Goodman and Weigle, 1981).
Low serum protein SH levels are generally a feature of active 
RA and have been shown to increase towards normal following 
clinical improvement (Lorber et al., 1971) and successful 
treatment with SH-containing antirheumatic drugs (Lorber, 
1966; Hall et al., 1981). Since immune mechanisms are 
intimately linked to the pathogenesis of RA and can be 
affected by thiols, the blocked SH groups found in active RA 
may, therefore, contribute to the defective immune responses 
in this disease. As mentioned earlier, adjuvant arthritis 
(AA) in rats is an experimental model of chronic inflammation
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that resembles RA both clinically and histopathologically 
(Pearson, 1979). Furthermore, defective immune mechanisms 
have also been implicated in the pathogenesis of AA. Using AA 
as a model, the aim of this project was (1) to determine the 
possible role and significance of SH groups in 
immunoregulation and their possible involvement in the 
immunopathogenesi s of AA, and (2) to identify the 
immunomodulant effects of D-penicillamine in this model.
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All chemicals, except where 
otherwise stated:
Sigma Chemical Co. Ltd., 
Poole.
All media reagents and 
tissue culture plastics, 
except where otherwise 
stated:
Gibco Bio-cult Ltd., 
Paisley, Scotland.
Concanavalin A (Lyophilised; 
from the jack bean Canavalia 
ensiforms):
Pharmacia, (G.B.) Ltd., 
Hounslow, Middx.
Ficol1-Hypaque (Density: 
1.007 + 0.001 g/ml); 
Sephadex G-10:
Pharmacia Fine Chemicals, 
(G.B.), Hounslow, Middx.
Heat-killed, mixed strains 
Mycobacteria; IL-2 (rat) 
standard:
Kindly donated by Lilly 
Research Centre, Windlesham,
IL-1 (Human) standard: Genzyme, Koch-light Ltd., 
Suffolk.
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Methyl [ ] -Thymidine 
(Specific activity 5Ci/mol, 
21 mCi/mg, Radioactive 
concentration ImCi/ml):
Radiochemical Centre Ltd., 
Amersham, Bucks.
Scintillation grade toluene; British Drug Houses (BDH) 
Ltd., Poole.
Scintillation vials; Richardsons of Leicester, 
Leicester.
2.2 Equipment Suppliers




Laborlux 12 microscope: E. letz (Instruments) Ltd., 
Luton.
MSE Chilspin 2 Centrifuge: MSE Laboratories Ltd., 
Irvine, Scotland.








All animals used were bred in the Bath University Animal House 
except Sprague-Dawley rats and rabbits which were purchased 
from Interfauna, Huntingdon, Cambridgeshire.
2.4 Routine buffers and media






Disodium hydrogen phosphate 0.48
Potassium dihydrogen phosphate 0.60 pH 7.3
The above were dissolved in 1 litre of distilled water, 
filter sterilised, and stored at 4°C. Before use, a 10 
fold dilution was performed with distilled water and the 
pH corrected to 7.3 with IM NaOH.
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Disodium hydrogen phosphate 11.50
Potassium dihydrogen phosphate 2.00 pH 7.3
The above were dissolved in 1 litre distilled water, 
filter sterilised (Millipore filter 0.45 ^m pore size) 
and stored at 4®C until required.
Before use, the solution was diluted to ten times its 
volume with distilled water. To this was added the 
equivalent of:
0.1 g/litre calcium chloride 
0.1 g/litre magnesium chloride
The pH was adjusted to 7.3 with IM sodium hydroxide 
solution.
2.4.3 Ammonium chloride solution
This solution was used for the lysis of extraneous red 




Potassium hydrogen carbonate 1.000
Ethelenediaminetracetic acid 0.004
The above were dissolved in 1 litre distilled water and 
the pH corrected to 7.4 with IM sodium hydroxide.
2.4.4 Lymphocyte culture medium RPMI 1640
Volume (ml)
RPMI 1640 (x 10 strength) 10.00
Penicillin/streptomycin solution 2.00
(5000 lU/ml of each)
200mM L-glutamine 2.00
7.5% sodium bicarbonate 2.70
Foetal calf serum 10.00 pH 7.4
The above mixture was diluted with 100 ml with sterile, 
distilled water. The pH was corrected to 7.4 with 
sterile IM sodium hydroxide.
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2.4.5 Scintillation fluid
To 2.5 litres of toluene was added:
12.50 g 2,5-Diphenyloxazole (PPO)
0.75 g 1,4-Di-2-( 4-methyl-5-phenyloxazolyl )- benzene 
(POPOP)
METHODS
(A) Determination of the total serum SH levels and the rate 
of SH-SS exchange reaction (SH reactivity)
2.1 Preparation of sera
Peripheral blood was taken by venipuncture from healthy 
volunteers. The blood was allowed to clot at 37*C. The 
clotted blood was centrifuged at 1000 r.p.m. for 10 minutes. 
The serum extracted from the first centrifugation was spun 
again for 10 minutes to ensure complete removal of 
erythrocytes and white cells. Sera were similarly prepared 
from blood obtained from mice, rats and guinea pigs via 
cardiac puncture under ether anaesthesia and rabbits by 
puncturing the ear veins. Both fresh sera and frozen sera 
(stored at -20°C) were used for experiments.
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2.2 5,5*-dithiobis (2-nitrobenzoic acid) (DTNB)
The reagent used for the determination of both total serum SH 
levels and SH reactivity was DTNB (Ellman, 1959). DTNB 
undergoes a SH-SS exchange reaction with the serum protein SH 
groups which may be represented by the reaction:
Protein-SH + DTNB -> Protein-S-S-TNB + TNB-SH (yellow)
The deep yellow product of this reaction, 5-thio-2- 
nitrobenzoic acid (TNB-SH,) may be determined 
spectrophotometrically at 440 nm (Butler et al., 1969). Only 
fresh DTNB solution was used. For the total serum SH assay 
the DTNB solution was added to a final concentration of 400 
pM. For the SH reactivity measurements, DTNB solution was 
added to a final concentration of either 100 piM or 400 pM. 
The DTNB was protected from u.v. degradation with aluminium 
foil and always preincubated at 37°C during experiments.
2.3 The total serum SH assay
The experimental design was as follows:
* Blank* cuvette (1 ml) 'Test' cuvette (1 ml)
50 |j1 serum 50 pi serum
950 pi 0.1 M phosphate buffer, 750 pi 0.1 M phosphate buffer,
pH 7.4 pH 7.4
200 pi DTNB solution (2mM)
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The reaction mixtures were incubated for 5 minutes at 37°C and 
the absorbance in the test cuvette was measured against the 
blank cuvette at 440 nm.
Based on this method, a calibration curve for the total serum 
SH assay was determined, using different concentrations of 
reduced glutathione (GSH). The absorbance measurements were 
carried out in a CE 595 double-beam digital U.V.
spectrophotometer (Cecil Instruments) which was linked to a CE 
530 cell programmer coupled to a CE500/Control-Record 
Module/Series Two. The CE 50 0/Control-Record Module was used 
to record the rate of SH-SS exchange reaction.
2.4 Determination of the rate of SH-SS exchange reaction 
(SH reactivity)
The experimental design was as follows:
'Blank' cuvette (1 ml) 'Test' cuvette (1 ml)
400 pi serum 400 pi serum
600 pi 0.1 M phosphate buffer, 400 pi 0.1 M phosphate buffer,
pH 7.4 pH 7.4
200 pi DTNB solution
The method for measuring SH reactivity was almost identical to 
that of the total serum SH assay except that the amounts of 
serum and buffer used were altered.
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The change in absorbance at 440 nm measured in the 
spectrophotometer (CE 595) was recorded via the CE500 Control- 
Recorder Module/Series Two which plotted the increase in 
absorbance against time (minutes) automatically. The gradient 
(absorbance/time) obtained from the graph plotted could be 
used to calculate the rate of SH-SS interchange reaction^us&ng 
thne-ŝ Gai-î r̂ atrion— cux.v-e-s*~~-siio4(m--in--Figureê — andr--'3 * 1 vc
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(B) Lymphocyte preparation
2.1 * Preparation of rat spleen and lymph node lymphocyte
suspensions
Male Wistar or Sprague-Dawley rats (150 - 250 g) were killed 
under ether anaesthesia by cervical dislocation. The spleens 
and mesenteric lymph nodes were aseptically removed and kept 
in sterile Nunc universels containing ice-cold RPMI 1640 
medium (pH 7.4) with Hepes buffer supplemented with 10% FCS, 2 
mM L-Glutamine and Penicillin/Streptomycin (100 lU/ml each). 
The spleen or lymph node was pressed through a sterile tea 
strainer into a sterile petri dish containing 8 ml of ice-cold 
CMFSS. The cells were then passed through a sterile silk 
filter to give a single cell suspension.
* CFLP mouse splenic lymphocyte suspensions were obtained 




The single cell suspension obtained in was then layered
onto 3 ml Ficoll-Paque (density 1.077 + 0.01 g/ml) contained 
in a sterile Nunc centrifuge tube and centrifuged at 400 g for 
30 minutes at 20°C. The mononuclear cells forming a discrete 
band at the interface were harvested and washed twice with 
CMFSS by gentle resuspension and pelleting at 400 g for 10 
minutes. The final pellet was resuspended in culture medium: 
RPMI 1640 supplemented with 5% FCS, 2 mM L-Glutamine, 0.75% 
sodium bicarbonate solution and penicillin/streptomycin (100 
lU/ml each).
2.3 Lymphocyte count and viabilities
Lymphocytes were enumerated using an improved Neubauer 
haemocytometer, and cell viabilities were assessed by trypan 
blue exclusion method.
2.4 Conditions of culture
Cells were diluted in culture medium. 200 îl aliquots of the 
diluted cell suspension were transferred to individual wells 
of a Nunc microtiter round-bottomed cell culture plate to 
which various compounds such as ConA, 2-ME etc. were added to 
stimulate lymphocyte proliferation. All cultures were 
performed in triplicate. The cell culture plates were
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cultured in a humidified atmosphere of 5% OO2 in air at 37°C.
2.5 Determination of lymphocyte proliferation
Cultures were harvested after 72 hours of incubation. For the 
final 4 hours before harvesting 0.5 |iCi of methyl [^H]- 
thymidine (specific activity 5 Ci/mmol) was added to each 
well. The cells were harvested with a Titertek cell harvester 
onto fibreglass filter papers. Cells were washed with 
distilled water, precipitated with 5% trichloroacetic acid 
(TCA) and dried with methanol. The filter papers were oven 
dried (37®C) overnight. Discs of filter paper were placed in 
mini-vials to which 2 ml of scintillation fluid were added. 
The resultant scintillation was determined with a Packard Tri- 
Carb liquid scintillation spectrometer and expressed as mean 
scintillation counts per minute (CPM).
(C) Interleukins
2.1 Interleukin-1 (IL-1) production
20 ml cold Phosphate buffered saline (PBS) supplemented with 
2% FCS (PBS/2% FCS) were injected peritoneally into male 
Sprague-Dawley rat (200-250 g) and the abdomen of rat was 
massaged for 10 minutes. Peritoneal macrophages (mç̂ s) were 
collected and centrifuged at 400 g for 10 mins. The cells 
were washed three times with cold PBS/2% FCS by gentle
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resuspension and pelleting at 400 g for 10 minutes. The final 
cell pellet was resuspended in RPMI 1640 medium supplemented 
with 10% FCS, 2 mM L-Glutamine, 100 lU/ml penicillin, 100 
lU/ml streptomycin and 0.75% sodium bicarbonate solution and 
counted in 0.2% trypan blue.
The cells were diluted in a concentration of 1 x 10^ cells/ml 
in culture medium. The diluted cell suspension was 
transferred in 1 ml aliquots into 6 x 4  large Nunc tissue 
culture plates and pre-incubated for one hour in a humidified 
atmosphere of 5% CO2 in air at 37®C with the following agents: 
2-ME (2.5 X 10”  ̂M) and an irreversible non-penetrating SH 
blocking agent, p-hydroxymercuriphenylsuIphonate (pHMPSA; 5 x 
10”  ̂M) to allow the adherent cells (mjzJs) to adhere to the 
plate.
At the end of the preincubation the plate was washed three 
times with cold pAS/2%/FCS to remove the non-adherent cells. 
1 ml of culture medium (with or without 2.5 x 10”  ̂M 2-ME 
incorporated) containing 1 pg of Lipopolysaccharide (EPS) was 
added to the appropriate well which was initially preincubated 
with or without 2-ME. Finally, the plate was incubated in the 
same culture condition for 24 hours before the supernatant 
(which contained IL-1 released by the m^s) was aspirated, 
centrifuged (at 500 g for 10 minutes) and filtered sterile 
through 0.22 pm filter prior to being aliquoted and stored at 
-20°C for later assay.
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2.2 IL-1 assay
Thymuses aseptically removed from *C3H/HeJ mice (6-8 weeks 
old) were trimmed of adipose tissue and pressed through a 
sterile tea strainer into a petri dish containing 10 ml of 
cold PBS/2% FCS. The thymocyte suspension was prepared as
B 2^
described in However, the final cell pellet was
resuspended in RPMI 1640 medium supplemented with 5% FCS 
instead of 10% FCS.
The adherent cells were separated by passage through a 
Sephadex G-10 column (10 ml) which had been pre-warmed to 
37®C. The non-adherent cells were collected, washed with cold 
PBS/2% FCZS and then adjusted to 10^ cells/ml in culture medium 
(5% FCS) containing 2-ME (2.5 x 10"^ M).
The IL-1 dilution was performed using the i dilution design
i.e. i -> 1/4096 in 12 wells. To the 100 pi/well diluted IL-1 
in culture medium [containing 2-ME (2.5 x 10“  ̂M)], cells were 
added in 100 pi (1 x 10^ cells) to give a total volume of 200 
pl/well. Nunc microtiter cell culture plates with flat 
bottoms were used.
The experimental design was as follows:
(a) Culture medium (control) + cells
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(b) Culture medium + IL-1 (Human) (commercial standard, 
Genzyme) + cells
(c) Culture medium + IL-1 (Human) + ConA (Ipg/ml) + cells
(d) Culture medium + IL-1 (Rat) + cells
(e) Culture medium + IL-1 (Rat) + ConA (1 pg/ml) + cells
The cells were incubated for 72 hours in a humidified
atmosphere of 5% CO2 in air at 37®C.
For the final 4 hours of incubation 0.5 pCi of methyl [ ̂ H ] - 
thymidine (specific activity, 5Ci/mmol) was added to each 
well. The cells were harvested at the end of the 72-hour 
incubation and incorporation of radioisotope measured asÊ-zf
previously described (see B»l;5). The capacity of each of the 
test supernatants to induce cell proliferation was calculated 
using probit-analysis and the following equation was used to 
convert the resulting titres (ED^q ) into units.
^50 (test) X 100 units/ml
ED^q (standard)
* C3H/Hej mice were used because they are LPS-resistant so 
that the thymocyte proliferation in the assay is not due to 
stimulation by LPS but through the IL-1 under test.
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2.3 Interleukin-2 (IL-2) production
IL-2 was produced by a short term exposure of lymphocytes to 
ConA followed by the removal of ConA by extensive washing of 
the cells prior to subsequent incubation in culture medium 
free of ConA (Spiess and Rosenberg, 1981).
The spleen cell suspension was prepared as described in (Ẑ lT.
The cell suspension was adjusted to 2 x 10^ viable cells/ml in 
culture medium containing 20 pg/ml ConA. The cells were mixed 
thoroughly in Nunc centrifuge tubes and pre-incubated upright 
at 37*C in 5% CO2 in air for 2 hours according to the 
following design:
Tube 1 Tube 2 Tube 3
No addition + 2-ME (2.5 x 10“  ̂M) + PHMPSA (5 x 10"%)
Following this incubation the tubes were centrifuged at 400 g 
for 10 minutes and the pellets washed three times with PBS/2% 
FCS. The final pellet was resuspended back to the original 
volume of ConA pre-incubation but in appropriate culture 
medium (with or without 2.5 x 10”  ̂M 2-ME) not containing 
ConA. The cells were not recounted. The cell suspension was 
then delivered in 1 ml aliquots to the wells of the large (6 x 
4) Nunc tissue culture plates with flat bottoms. The plates 
were incubated for 24 hours in a humidified atmosphere of 5%
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CO2 in air at 37°C. The supernatant was then harvested, 
centrifuged at 500 g for 10 minutes and filtered through a 
0.22 pm filter prior to being aliquoted and stored at - 20°C 
before assay.
2.4 IL-2 assay
Spleens obtained aseptically from C3H/HeJ mice 8-12 weeks old 
were pressed through a sterile tea strainer into a petri dish 
containing 10 ml of cold PBS/2% FCS and the spleen cell 
suspension was prepared as describd in The final cell
pellet was resuspended in culture medium (RPMI 1640 
supplemented with 10% FCS, 2mM L-Glutamine; Penicillin/ 
streptomycin (100 lU/ml each) 0.75% sodium bicarbonate 
solution) containing 2.5 x 10"^ M 2-ME and 3 pg/ml ConA.
The cells were distributed to the large (6 x 4) Nunc tissue 
culture plate at 2 ml/well and incubated for 72 hours at 37°C 
in a humidified condition with 5% CO2 in air.
At the end of the 72-hour incubation the cells were harvested 
and spun at 400 g for 10 minutes. The cells were washed three 
times and the final cell pellet was resuspended in cultured 
medium containing RPMI 1640, 5% FCS, 2mM L-Glutamine,
Penicillin/streptomycin (100 lU/ml each) 0.75% sodium 
bicarbonate solution, and 2.5 x 10“  ̂M 2-ME.
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The cells were counted and diluted to 2 x 10^/ml in culture 
medium containing 2.5 x 10“  ̂M 2-ME. These cells were used 
for IL-2 assay.
The IL-2 dilution was done using the same method as that of 
IL-1 assay, i.e. idilution design; 1/2 -> 1/4096 in 12 wells. 
Round bottomed Nunc microtitre cell culture plates were used. 
To the 50 pl/well diluted IL-2 in culture medium containing
2.5 X 10~5 2-ME, 50 pi of medium containing 2 x 10^ cells/ml
was added to give a total volume of 100 pi/well.
The experimental design was as follows:
(a) culture medium (control) + cells
(b) culture medium + IL-2 (PVG rat/Lilly)^ + cells
(c) culture medium + IL-2 (male Sprague-Dawley rat) + cells
The cells were incubated for 24 hours and then pulsed with 0.5
pCi methyl [̂ H]-thymidine (specific activity 5 Ci/mmol) for 4
hours before they were harvested and radioactivity determined
as described in B^K’5. The capacity of each of the test
supernatants to induce cell proliferation was calculated using
probit analysis and the resulting titres (ED̂ g) were converted
C' 2"% '
into units/ml. using the same equation shown in
^ IL-2 (PVG rat/Lilly) was included as standard and control. 
It was kindly supplied by Lilly Research Centre, Windlesham.
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(D) Short term treatment of adjuvant ctrthritis (AA) in rat
%fith D-peni ci llamine
2.1 Experimental design
Male inbred Sprague-Dawley rats weighing 200-250 g were used 
throughout.
The animals were divided into 2 groups as follows:
(a) Control (arthritic)
(b) Arthritic + D-penicillamine treatment
2.2 Induction of arthritis
Polyarthritis was induced by a single injection into the rat 
hind paws of 0.1 ml heat-killed, mixed strains of mycobacteria 
in mineral oil at a concentration of 5.5 mg/ml. The 
mycobacteria were ground in a pestle and mortar before adding 
to the mineral oil.
Certain groups of animals were dosed with D-penicillamine (50 




—7 +2 +4 +7 +10 +14 +17 +21
Induction of arthritis
Duration of D-penicillamine treatment (50 mg/Kg/day, p.o.)
D-penicillamine was administered to the rats 7 days prior to 
induction of arthritis followed by daily treatment throughout 
the development of arthritis (up to day 21). Normal control 
animals received equivalent volumes of normal saline.
2.3 Evaluation of arthritis
Several parameters were used to assess the arthritis.
(1) Weight change (Winder et al., 1969). Changes in body 
weight and retardation in weight gain was used to monitor the 
course of the disease and the response to therapy with D- 
penicillamine. It was measured throughout the experiments.
(2) Size of hind paws; Circumferences (Aspinall and 
Cammarata, 1969) of the injected feet and the non-injected 
ones were measured using a modified caliper gauge with a 
Vernier scale.
(3) Severity of arthritic lesions (Currey and Ziff, 1968). 
This was based on the degree of joint involvement in the four
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paws. Severity of arthritic lesions was graded using a 
scoring system of 1+ = detectable, 2+ = moderate, 3+ = severe 
for each inflamed paw. Max. score = 12+.
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CHAPTER THREE: RESDLT A
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RESULT A: SERUM SULPHYDRYL LEVEL AND REACTIVITY
3.1 Serum sylphydryl levels and sulphydryl-di sulphide (SH-SS) 
exchange reactions
There are two distinct assay methods for thiols; the first 
measures the rate of SH-SS exchange reaction (reactivity) and 
the second quantifies total serum SH. Total serum sulphydryls
and their reactivity were initially studies in a number of
healthy animal species including man. Later, the study was 
extended to include sera from adjuvant-induced arthritic (AA) 
rats and D-penicillamine treated AA rats.
3.1.1 Calibration curve for total serum SH assay
The calibration curve for total serum SH assay is illustrated 
in Fig. 3.1.a. It was determined using the reaction of known 
concentrations of reduced glutathione (GSH) solution with 
DTNB. The conversion of the absorbance of a given serum to 
total serum SH level (expressed as pmol (SH)1~̂ ) was achieved 
by reading directly from the calibration curve.
3.1.2 Total serum SH level in different species
The results presented in Table 1 show that healthy humans had
significantly higher serum SH levels than any other of the 
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Fig. 3.1.a. The calibration curve for total serum 
SH assay. The results are expressed 




Serum SH LEVEL (/imol P )
X ±  s.d RANGE
HUMAN 
(n = 14) 538 ± 42 446—614
RABBIT 
(n = 15) 376 ± 45 308—468
GUINEA-PIG 
(n = 13) 270 ±  44 208—354
RAT 
(n = 19) 302 ±  33 230—358
MOUSE 
(n = 24) 388 ±  59 276—556
TABLE 1. The total serum protein SH level of different 
species. The results are expressed as mean + 1 s.d.
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serum SH level was 538 pmol (SH) 1“ .̂ It is of interest to 
note that the mean total serum SH level of the mouse was 
significantly higher than that of the rat.
3.1.3 Determination of rate of serum SH reaction (reactivity)
Owing to the differences in serum SH reactivity of the animal 
species studied, two different DTNB concentrations had to be 
used to obtain comparative data. Preliminary experiments 
showed that the SH reactivity of the rat and mouse serum SH 
groups with a final DTNB concentration of 400|iM was extremely 
fast and plateau was reached instantly. Since there is a non­
linear increase in reaction rate with the increase of DTNB 
concentration, all reactions should be carried out at one DTNB 
concentration. However, this was not possible as the reaction 
rate of different serum samples varied considerably with a 
final DTNB concentration of 400pM. To enable a comparison, 
some species had their serum SH reactivity determined at DTNB 
concentration of 400pm. As the human and rabbit sera had 
reasonably fast reaction rates with the 400pM concentration, 
it was still possible to determine the serum SH reactivity of 
these species at the lower (lOOpM) DTNB concentration although 
the reaction rates were much slower. The serum SH reactivity 
of the rat and the mouse could only be measured at lOOpM DTNB 
concentration. In contrast, the guinea-pig serum SH 
reactivity could only be determined at DTNB concentration of 
400pM. The reaction rate was far too slow when lOOpM DTNB
- 96 -
concentration was used instead.
For the purpose of comparison, the changes in absorbance 
during the first minute (between 0 and 1 minute) and the 
second minute (between 1 and 2 minutes) respectively, were 
used to calculate the reaction rates. The increase in 
absorbance between 1 and 2 minutes yielded more consistent 
data because the increase in absorbance was linear during this 
time interval. The change is absorbance during the first 
minute could vary considerably between individual samples 
(Hall and Gillan, 1979). The initial rapid reactivity may 
partly represent the interaction of non-protein low molecular 
thiols with DTNB (Jocelyn, 1962).
Table 2 shows the results of the serum SH reactivity of human, 
rabbit and guinea-pig measured at 400pM DTNB. The rabbit 
appeared to have the fastest serum SH reactivity at both first 
minute and second minute measurements. The statistical data 
in Table 3 show that the serum SH reactivity of the guinea-pig 
was significantly lower than those of both rabbit and human at 
both first and second minute measurements. The serum SH 
reactivity of rabbit was significantly faster than that of the 
man. Tables 4 and 5 show the results of the serum SH 
reactivity of human, rabbit, rat and mouse measured at lOOpM 
DTNB. The rat has significantly faster serum SH reactivity 
than those of the rabbit and human at both first and second 
minute measurements. Although the serum SH reactivity of the
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(n = 14) 58 ± 6 43 ±  3
RABBIT 
(n = 18) 94 ± 16 52 ± 6
GUINEA-PIG 
(n = 12) 13 ± 3 11 ±  3
TABLE 2. The serum protein SH reactivity of different 
species measured at 400pM DTNB. The results 
are expressed as mean + 1 s.d.
SPECIES (NORMAL) 1st Minute 2nd Minute
HUMAN vs RABBIT P<0.01 P<0.05
HUMAN vs GUINEA-PIG P<0.01 P<0.01
RABBIT vs GUINEA-PIG P<0.01 P<0.01
TABLE 3. Statistical analysis of results of TABLE 2 using 
Student ’t’ test.
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13 ±  3 8 ±  1
RABBIT 
(n = 18) 4 ± 1
4 ±  1
RAT 
(n = 18) 98 ±  14
35 ±  7
MOUSE 
(n = 11)
54 ±  19 29 ± 4
TABLE 4. The serum protein SH reactivity of different 
species measured at lOOpM DTNB. The results 
are expressed as mean + 1 sd.
SPECIES (NORMAL) 1st Minute 2nd Minute
HUMAN vs RABBIT P<0.01 P<0.01
HUMAN vs RAT P<0.01 P<0.01
HUMAN vs MOUSE P<0.01 P<0.01
RABBIT vs RAT P<0.001 P<0.001
RABBIT vs MOUSE P<0.01 P<0.01
RAT vs MOUSE P<0.01 N.S.
TABLE 5. Statistical analysis of results of TABLE 4 using 
Student ’t’ test.
- 99 -
rat is significantly faster than that of the mouse at the 
first minute measurement there is no difference in the second 
minute measurement. The rat serum SH reactivity is 7 times 
faster than that of the human in the first minute measurement 
and 4 times faster in the second measurement. It must be 
noted that both the rat and mouse sera oxidised rapidly when 
exposed to air. Rate measurements of their sera had to be 
made quickly (within an hour after their sera were extracted) 
to avoid oxidation of the free SH groups. By contrast, the 
serum SH groups of the human, rabbit and particularly guinea- 
pig remained relatively stable. The faster reaction rates of 
both the rat and mouse serum SH groups may be indicative of 
the intrinsically very reactive serum SH groups that these 
animals have. It is also interesting to see that at 400pM 
DTNB, the rabbit serum SH reactivity is significantly faster 
than that of the human while at lOOpM DTNB the human serum SH 
reactivity is faster than that of the rabbit although not 
significantly.
Experiments were also carried out to find out if there is any 
difference in the total serum SH concentrations and reactivity 
between two different strains of rat i.e. male CFHB Wistar and 
male CFY Sprague-Dawley animals. The results in Tables 6 and 
7 indicate that there was no significant difference in both 
the serum SH level and the reactivity between these two 
strains of rat. The lower values of the serum SH levels and 
reactivity were due to freezing (see below).
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SERUM SH LEVEL 
(pmol.M) 222 ± 20 258 ± 11
TABLE 6. Comparing the total serum protein SH level of 
two different strains of rat i.e. male CFHB Wistar 
rat and male CFY sprague-Dawley rat. All rat 
sera were frozen at -20®C for 2 days prior being 
analysed. The results are expressed as mean t s.d.
STRAIN CF RAT Wistar (CFHB) (n = 6)
Sprague-Dawley rat (CFY) 
(n = 6)
SERUM SH REACTIVITY 
(pmol(SH)l^min^)
1st Minute 2nd Minute 1st Minute 2nd Minute
96 ± 12 34 ±  2 94 ±  6 32 ±  3
TABLE 7. Comparing the serum protein SH reactivity of male 
CFHB Wistar rat and male CFY Sprague-Dawley 
rat. All rat sera were frozen at -20®C for 2 days 
prior being analysed. The results are expressed 
as mean + 1 s.d.
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3.1.4 Effect of freezing on total serum SH levels and 
reactivity
As shown in the results of Tables 8 and 9, freezing process 
depressed the serum SH level and reactivity of both the rat 
and guinea-pig sera, respectively. The sharp fall in SH level 
and reactivity of both the rat and guinea-pig sera occurred 
during the first two weeks after storage at -20°C. 
Thereafter, the serum SH level and reactivity reached almost 
constant level but remained much lower than those of the fresh 
control sera. This observation suggests that the freezing 
process may induce certain conformational changes in the serum 
protein molecules resulting in less free SH groups available 
for reaction with DTNB and hence a reduction in serum SH level 
and reactivity.
3.1.5 Adjuvant arthritis (AA) in rat and its treatment with 
D-Pen
As will be seen later, a rather different pattern of serum SH 
level and reactivity was found in rats that developed 
arthritis after a single injection of complete Freund's 
adjuvant (CFA) and AA rats receiving daily oral D-Pen 
treatment (50 mg.Kg.” )̂. Before looking at the results of 
these experiments it is appropriate to examine (1) the effect 
of induction of polyarthritis in male Sprague-Dawley rats and




SERUM SH LEVEL 
(pmol.l'^)
SERUM SH REACTIVITY (pmol(SH)rmin^)
1st MINUTE 2nd MINUTE
0 (FRESH) 288 ± 6 92 ± 7 33 ± 6
2 94 ± 3 59 ± 8 25 ± 3
4 90 ± 5 53 ± 3 24 ± 3
6 102 ± 4 53 ± 5 22 ± 3
TABLE 8. Depressed rat serum protein SH level and reactivity over 6 weeks of storage at -20®C. The 
results shown above were based on the analysis of 
aliquots of pooled rat sera on a fortnightly basis. 
All determinations were performed in triplicate. 
The results are expressed as mean + 1 s.d.
WEEKS AFTER 
STORAGE AT -20°C
SERUM SH LEVEL 
(pmol.M)
SERUM SH REACTIVITY (pmol(SH)rmin-^)
1st MINUTE 2nd MINUTE
0 (FRESH) 182 ±  6 27 ± 5 19 ± 4
2 120 ±  4 17 ±  2 17 ± 3
4 96 ± 4 15 ±  3 14 ± 3
6 108 ±  4 14 ±  2 13 ± 2
8 94 ± 5 14 ± 3 14 ± 3
TABLE 9. Depressed guinea-pig serum protein SH level and 
reactivity over 8 weeks of storage at -20®C. The 
results shown above were based on the analysis of 
aliquots of pooled rat sera on a fortnightly basis. 
All determinations were performed in triplicate. 
The results are expressed as mean + 1 s.d.
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these rats.
When 0.1 ml. of CFA containing heat-killed M. tuberculosis at 
a concentration of 5.5 mg.ml”  ̂was injected into the right 
hind paws of male Sprague-Dawley rats, an intense but 
transient inflammatory response occurred. This initial phase 
of acute inflammatory response was local and produced no other 
obvious sign in the animals. In the next two weeks necrosis 
of the innoculation sites was observed but the animals 
appeared healthy. On about 14 days after CFA injection, a 
marked change occurred in the severely affected animals. 
There was extensive inflammation in areas remote from the 
injected sites, arthritis and periarthritis suddenly appeared 
in the joints of the extremities, especially in the distal 
small joints of the hind paws, which were characterised by 
redness and swelling or varying severity and painfulness. The 
forepaws and tails of the rats showed swelling and became 
slightly enlarged. The severely affected animals lost weight 
although a retardation in weight gain was recorded with almost 
all the animals that developed arthritis.
The majority of the animals studied responded well to the CFA 
and developed arthritis. However, it must be stressed that 
the arthritis induced in these Sprague-Dawley rats was not of 
a very severe nature. Non-articular lesions involving skin, 
eyes, nose and urogenital tract were not observed in some of 
the animals that developed arthritis although the tails and
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forepaws of these animals were affected and showed signs of 
inflammation.
D-Pen (50 mg.Kg.”  ̂day“ )̂ was administered orally to some rats 
7 days prior to induction of arthritis followed by treatment 
throughout the development of arthritis (up to 21 days).
The effects of D-pen treatment on the various parameters used 
to assess the arthritis i.e. size of hind paws, arthritis 
score and weight change will now be examined.
As illustrated in Fig. 3.2.a a steady increase in size of 
injected paws occured from days 2 to 21. The increase was 
more marked after day 10 - the time of onset of AA. The non­
injected paws showed no increase in size until day 7, 
thereafter a slow but steady increase in size was observed. 
The hind paw circumference of the normal control animals 
showed little increase. In vivo D-pen treatment did not 
induce any reduction in size of either injected or noninjected 
paws of AA rats. In fact, in vivo D-Pen treatment appeared to 
slightly exacerbate the swelling of the injected paws from 
days 14 to 21 and this was confirmed by the arthritis score 
shown in Fig. 3.2.b. In vivo D-Pen treatment did not improve 
the arthritis score from days 2 to 10. However, it tended to 
increase the arthritis score from days 14 - 21. Fig. 3.2.C 
shows the effect of in vivo D-Pen treatment on body weight 
change. Reduction in weight gain in AA rats started on day 2
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Healthy normal control 
AA/injeted paw 













Fig. 3.2.a. The effect of D-penicillamine (D-Pen) 
treatment (50 mg.Kg.'^day” ,̂ orally) 
on the hind paw circumference of 
Sprague-Dawley rats during 
development of AA (n = 6, at each 
time interval). The results are 













Fig. 3.2.b. The effect of D-Pen treatment (50 
mg.Kg.“^day” ,̂ orally) on arthritis 
scores during the development of AA 
in male Sprague-Dawley rats (n = 6, 
at each time interval). The results 














Fig. 3.2.C. The effect of D-Pen treatment (50 
mg.Kg.“^day“ ,̂ orally) on body weight 
changes during the development of AA 
in male Sprague-Dawley rats (n = 6, 
at each time interval). The results 
are expressed as mean + 1 s.d.
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when compared to normals. The AA rats gained only 40g. in 
weight compared to 86g. weight gain in normals. Again, 
in vivo D-Pen treatment did not improve the pattern of 
reduction in weight gain.
3.1.6 Total serum SH levels during development of AA
The serial changes which occurred in the total serum SH levels 
during the course of AA are shown in Fig. 3.3.a. A rapid fall 
in serum SH level occurred during the acute inflammatory 
phase, i.e. days 0 to 4 (P < 0.01 at day 2; P < 0.01 at day 4 
Vs day 0). At about the time of onset of AA (between day 10 
and day 17) a further decline in serum SH level was observed 
(P < 0.001 at day 14 Vs day 0). The serum SH level began to 
rise slightly from day 17 onwards although it still remained 
significantly lower than that of the control (P < 0.01 at day 
21 Vs day 0).
As shown in Fig. 3.3.b similar serial changes in SH levels 
were observed in the D-Pen treated (50 mg.Kg.“^.day” ,̂ orally) 
AA rat serum samples during the acute inflammatory period i.e. 
days 0 to 4 (P < 0.05 at day 2; P < 0.01 at day 4, Vs day 0). 
Thereafter, the serum SH level declined slowly until it 
reached its lowest level at day 10 (P < 0.001 Vs day 0) 
instead of day 14 with serum from AA rat not treated with D- 
Pen. In vivo D-Pen treatment increased the serum SH level of 











Fig. 3.3.a. The total serum protein SH levels 
during development of AA in male 
Sprague-Dawley rats (n = 6, at each 
time interval). The results are 
expressed as mean _+ 1 s.d.











Fig. 3.3.b. The effect of D-Pen treatment on the 
total serum protein SH levels during 
development of AA in male Sprague- 
Dawley rats (n = 6, at each time 
interval). The results are expressed 
as mean + 1 s.d. (Statistical
analysis used: Student "t" test).
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had no significant effect on serum SH levels in normal rats.
3.1.7 Serum SH reactivity during development of AA
The serial changes in the serum SH reactivity during the 
course of AA are shown in Fig. 3.4.a. From the kinetic 
profile of the "first minute measurements", the changes in 
serum SH reactivity followed a similar pattern of the AA total 
serum SH level. A sharp fall in serum SH reactivity was 
observed in the acute inflammatory phase i.e. days 0 to 4 (P < 
0.01 at day 2; P < 0.001 at day 4 Vs day 0). A further 
decline in serum SH reactivity was recorded about the time of 
onset of AA on days 10 to 14 (P < 0.001 on day 14 Vs day 0). 
However, the serum SH reactivity increased back to the level 
seen in the acute inflammation phase by day 17 (P < 0.001 Vs 
day 0) and was still rising at day 21 (P < 0.05 Vs day 0). 
The serial changes in serum SH reactivity measured via the 
"second minute method" presented a similar pattern as those 
measured via the "first minute method" although the depression 
of serum SH reactivity appeared to be less marked and more 
gradual. A sharp fall in serum SH reactivity was seen from 
days 0 to 2 (P < 0.001 Vs day 0). It then declined slowly 
from day 2 until it reached its lowest level at day 14 (P < 
0.001 Vs day 0) i.e the time of onset of AA. Thereafter, the 
serum SH reactivity started to increase gradually towards 
normality although it was still significantly lower than that 
of the normal control level by day 21 (P < 0.01).
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1st min 















Fig. 3.4.a. Serum SH reactivity during 
development of AA in male Sprague- 
Dawley rats (n = 6, at each time 
interval). The results are expressed 
as mean ^ 1 s.d. (Statistical 
analysis used: Student "t" test).
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From the kinetic profile of the "first minute curve" shown in 
Fig. 3.4.b the serial changes in the serum SH reactivity of 
the D-Pen treated AA rats were different from those seen in 
untreated AA. The serum SH reactivity fell sharply and 
rapidly to the lowest point at day 4 (P < 0.01 Vs day 0). 
Interestingly, the reactivity curve began to rise slowly 
towards normality by day 21. The kinetic profile of the 
"second minute curve" bore some resemblance to the "first 
minute curve". The serum SH reactivity curve fell steadily to 
its lowest level at day 4 (P < 0.05 Vs day 0). Then it 
started to rise slowly from day 4 to day 7 (P < 0.05 Vs day 0) 
and it reached normality at day 10 and was still rising at an 
even slower rate over days 17 - 21.
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Fig. 3.4.b. The effect of D-Pen treatment on the 
serum SH reactivity during 
development of AA in male Sprague- 
Dawley rats. (n = 6, at each time 
interval). The results are expressed 
as mean + 1 s.d. (Statistical
analysis used: Student "t" test).
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CHAPTER POOR: RESOLT B
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RESULT B: EFFECTS OF 2-MERCAPIOETHANOL AND D-PENICILLAMINB
ON THE IMMUNE FUNCTION OF RATS WITH ADJUVANT 
ARTHRITIS
4.1 Lymphocyte reactivity of rats with AA
The aim of this investigation was to determine (1) if the 
altered lymphocyte reactivity in RA also occurred during 
disease development of AA in rats, (2) whether the addition of 
2-ME in vitro and D-Pen treatment in vivo might modulate 
immune function in AA rats and in mice. The investigation 
started off with determining the effect of 2-ME and a T-cell 
mitogen (ConA) on the proliferative responses of mouse spleen 
cells in culture and this was extended to study the effects of 
these agents and D-Pen treatment on the proliferative 
responses of AA rat spleen cells (SC) and lymph node cells 
(LNC) in culture.
4.1.1 Experiments with mouse spleen cell (SC) cultures
The ability of 2-ME to activate DNA synthesis was investigated 
in cultures of SC from male CFLP mouse. The results shown in 
Fig. 4.1.a show that 2-ME stimulated the incorporation of [̂ H] 
thymidine into DNA in a dose-dependent manner. Peak [^H]
thymidine incorporation occurred at a 2-ME concentration of 5 
X 10 M̂. Lpwer 2-ME concentrations appeared to be inhibitory.
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Fig. 4.1.a. The effect of 2-ME on the DNA 
synthesis of male CFLP mouse spleen 
cells in culture (n = 5). The 
optimal level of 2-ME required to 
stimulate spleen cell proliferation 
was 5 X 10“^M. The results are 
expressed as mean + 1 s.d.
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ME was 33 times higher than the control level.
The results shown in Fig. 4.1.b indicate that ConA, like 2-ME, 
also promoted DNA synthesis in a dose-dependent fashion. 
Maximal [%] thymidine incorporation into DNA occurred at ConA 
concentration of 5 |jig.ml“ .̂ A lower incorporation occurred at 
lower concentrations and inhibition was observed at very high 
concentration (50 to 100 pig.ml“ )̂. The peak ConA stimulated 
incorporation was 82 times higher than the control level.
The result in Fig. 4.1.C shows that the addition of 2-ME (5 x 
10”^M) to ConA stimulated mouse SC produced only an additive 
proliferative response at 1 to 10 pg.ml"^ ConA. The peak 
proliferative response occurred at 5 pg.ml”  ̂ConA in the 
presence of 2-ME (5 x 10”^M).
4.1.2 Experiments with rat spleen and lymph node cell (LNC) 
cultures
The ability of 2-ME to stimulate DNA synthesis was also 
studied in male Wistar rat SC in culture. Fig. 4.2.a shows 
that 2-ME promoted the incorporation of [ ] thymidine into
DNA in the same way it did in the mouse system i.e. in a dose- 
related fashion. Again, peak proliferative response occurred 
at a 2-ME concentration of 5 x 10~^M. Suboptimal doses 
resulted in suboptimal [^H] thymidine incorporation and 

















control 10 50 100
Fig. 4.1.b. The effect of ConA on the DNA 
synthesis of male CFLP mouse spleen 
cells in culture (n = 5). The 
optimal level of ConA needed to 
stimulate spleen cell proliferation 
was 5pg.ml."l. The results are 
expressed as mean + 1 s.d.
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Fig. 4.I.e. The effect of various concentrations 
of ConA, in the presence of 5 x 10”^M 
2-ME on the proliferative response of 
male CFLP mouse spleen cells in 
culture (n = 5). The results are 
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Fig. 4.2.a. The effect of 2-ME on the DNA 
synthesis of male Wistar rat spleen 
cells in culture (n = 5). The 
optimal dose of 2-ME required to 
stimulate spleen cell proliferation 
was 5 X 10“^M. The results are 
expressed as mean + 1 s.d.
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peak 2-ME stimulated response was about 6 times the control 
value.
As shown in Fig. 4.2.b ConA stimulated DNA synthesis of male 
Wistar rat SC in culture in a dose-dependent manner. Maximal 
[̂ H] thymidine incorporation occurred at 5 pg.ml"^ ConA. High 
concentrations were inhibitory while lower concentrations 
induced suboptimal response. The peak ConA-induced response 
was about 6 times bigger than the control level.
The result in Fig. 4.2.C shows that the addition of 2-ME (5 x 
10“^M) to ConA stimulated rat SC produced a big enhancement of 
response at 1 to 10 pg.ml”  ̂ConA. Maximal response occurred 
at 5 îg.ml”  ̂ConA. 2-ME had no enhancing effect at high ConA 
concentrations (50 - 100 ijg.ml"^). It was probably because 
high doses of ConA poisoned the SC in culture. The peak 2-ME 
stimulated enhancement of ConA response (16830 + 2899) was 
about 5 times bigger than the sum of individual responses of 
2-ME (1660 + 240) and ConA (1746 + 462) respectively.
In order to establish the optimal time needed for SC in 
culture the kinetic profile of the proliferative responses of 
rat SC in culture was investigated. As the results in Fig. 
4.3.a indicates that maximal proliferative response of control 
culture as well as those stimulated by 2-ME (5 x 10” M̂), ConA 
(5 ng.ml."^) and 2-ME + ConA occurred at day 3 (72 hours). 
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Fig. 4.2.b. The effect of ConA on the DNA 
synthesis of male Wistar rat spleen 
cells in culture (n = 5). The 
optimal dose of ConA needed to 
stimulate splepn cell proliferation 
was 5 ^g.ml.^l. The results are 
expressed as mean + 1 s.d.
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Fig. 4.2.C. The effect of various concentrations 
of ConA, in the presence of 5 x 10”^M 
2-ME on the proliferative response of 
male Wistar rat spleen cells in 
culture (n = 5). The results are 
expressed as mean + 1 s.d.
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Day of C u ltu re
Fig. 4.3.a. Kinetic profile of the proliferative 
response of male Wistar rat spleen 
cells (SC) in culture (n = 3, at each 
time interval) to 2-ME (5 x 10~^M), 
ConA (5|ig.ml.~ ) and 2-ME + ConA. 
The results are expressed as mean + 1 
s.d.
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stimulated responses starting from day 2, reaching the peak 
level at day 3, and declining thereafter.
As shown in Fig. 4.3.b the peak proliferative response of 
control Wistar rat LNC culture occurred at day 3. This was 
also true with the responses stimulated by 2-ME (5 x 10”^M), 
ConA (5 pg.ml."̂ ) and 2-ME + ConA. Again, enhancement of ConA 
stimulated responses by 2-ME was observed.
4.1.3 Effect of 2-ME, ConA and 2-ME + ConA on the
proliferative responses of rat SC during development 
of AA
As illustrated in Fig. 4.4.a the proliferative response of AA 
rat SC stimulated with 2-ME (5 x 10“^M) was markedly depressed 
2 days after induction of disease (P < 0.001 Vs day 0). It 
increased modestly at day 7 and maintained at that level 
thereafter. The ConA (5 jig.ml. ^) stimulated response 
increased sharply at day 2 of induction of disease. It then 
declined sharply until it became markedly depressed at day 14 
(P < 0.001 Vs day 0) the time of onset of AA. Thereafter, it 
began to increase towards normal. The addition of 2-ME 
apparently enhanced the ConA stimulated response at all the 
time intervals studied. 2-ME not only restored the depressed 
ConA response at day 14, it also enhanced the ConA réponse to 
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Fig. 4.3.b. Kinetic profile of the proliferative 
responses of male Wistar rat lymph 
node cells (LNC) in culture (n = 3, 
at each time interval) to 2-ME (5 x 
10"^M), ConA (5 pg.ml."^) and 2-ME + 
ConA. The results are expressed as 
mean + 1 s.d.
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Fig. 4.4.a. The effects of 2-ME (5 x 10" M) and 
ConA (5 jig.ml. ” ) on the
proliferative response of male 
Sprague-Dawley rat SC (n = 6, at each 
time interval) during the development 
of AA. The results are expressed as 
mean + 1 s.d. (Statistical analysis: 
Mann-Whitney U test).
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The tendency of the proliferative responses stimulated with 2- 
ME, ConA and 2-ME + ConA to normal levels as early as day 21 
implies that the AA induced in these Sprague-Dawley rats was 
not of a very severe nature.
4.1.4 Effect of 2-ME, ConA and 2-ME + ConA on the
proliferative response of D-Pen treated SC during 
development of AA
The result in Fig. 4.4.b indicates that there was a decrease 
in 2-ME (5 x 10"^M) stimulated proliferative response of D-Pen 
treated AA rat SC at day 2 (P < 0.001 Vs day 0) and day 7 (P < 
0.01 Vs day 0) of AA. Thereafter, it began to increase back 
to D-Pen treated normal level. The initial increase in Con A 
(5 pg.ml."^) stimulated response at day 2 as seen in the AA 
rat SC was markedly decreased in D-Pen treated AA rat SC (P < 
0.001). The markedly inhibited response to ConA on day 14 of 
AA rat SC was reverted to marked enhancement of response (P < 
0.001). The ConA stimulated response fell slightly below the 
D-Pen treated normal level at day 21. The addition of 2-ME to 
the culture greatly enhanced the ConA stimulated response of 
D-Pen treated AA rat SC. Although the proliferative response 
induced by 2-ME + ConA initially decreased slightly below the 
D-Pen treated normal control level at day 2 it began to 
increase steadily thereafter and became significantly higher 
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Fig. 4.4.b. The effects of 2-ME (5 x lO^^M) and 
ConA (5 jig.ml. ) on the 
proliferative response of SC in D-Pen 
treated (50 ing.Kg.”^day orally) AA 
induced in male Sprague-Dawley rats 
(n = 6/ at each time interval). The 
results are expressed as mean + 1 
s.d. (Statistical analysis; Mann- 
Whitney U test).
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4.1.5 Proliferation response of normal and D-Pen treated 
normal rat SC
Short-term D-Pen treatment (50 mg.Kg.”^.day~^ orally for 7 
days) of normal Sprague-Dawley rats did not affect the 
background proliferative response of unstimulated SC as shown 
in Table 10. However, the 2-ME (5 x lO'^M) stimulated 
response was significantly depressed in D-Pen treated normal 
rat SC (P < 0.01, Mann-Whitney U test). In vivo D-Pen 
treatment induced a marked increase in ConA stimulated 
response in normal rat SC (P < 0.01, Mann-Whitney U test). 
The enhancing effect of 2-ME on the ConA stimulated response 
was also significantly higher in the D-Pen treated normal rat 
SC than the untreated normal SC.
4.1.6 Effect of 2-ME and ConA on the proliferative response 
of rat LNC during development of AA
There was a significant increase in the ConA (5 pg.ml.” )̂ 
stimulated proliferative response of AA rat LNC 2 days after 
the induction of disease (P < 0.001 Vs day 0) as illustrated 
in Fig. 4.4.C. However, by day 7 the ConA stimulated response 
dropped back to control level and became markedly depressed at 
day 14 (P < 0.001 Vs day 0) the time of onset of AA. However, 
it increased to slightly lower than normal control value at 
day 21. The addition of 2-ME (5 x 10”^M) stimulated a 
variable pattern of response. A significant decrease in
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ADDITION NO TREATMENT D-PEN TREATMENT (7 days)
0 217 ± 24 154 ± 71
2-ME 1213 ± 100 860 ± 159
ConA 2483 ±  358 8112 ± 2249
2-ME 4-ConA 15967 ± 2953 28911 ± 587
TABLE 10. The effects of 2-ME (5x10"5m ), Con A
and 2-ME + Con A on the proliferative responses 
of normal and D-PEN treated (50 mg.kg.”̂  day"̂ , 
orally for 7 days) normal Sprague-Dawley rat SC. 
The results are expressed as mean t 1 s.d.
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Fig. 4.4.C. The effects of 2-ME (5 x 10” M) and 
ConA (5 |j g . m 1 . ” ) on the
proliferative response of male 
Sprague-Dawley rat LNC (n = S), at 
each time interval) during 
development of AA. The results are 
expressed as mean _+ 1 s.d.
(Statistical analysis: Mann-Whitney U 
test).
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proliferative response occurred at day 2 of disease (P < 
0.001) and it increased back to day 0 level at day 7. It 
showed a depressed response at day 14 and increased again to 
control level by day 21. 2-ME induced an enhancement of ConA 
stimulated response of AA rat LNC to above that of the normal 
control rat LNC at day 2 of disease (P < 0.001). The 2-ME + 
ConA induced response fell slightly at day 7 (but still 
significantly higher than the control value, P < 0.001) and 
remained at that level even at day 14 when the rat became 
arthritic. Thereafter it declined to control ConA stimulated 
level.
Again, the tendency of the proliferative response stimulated 
with 2-ME, ConA and 2-ME + ConA to normal levels at day 21 was 
observed, implying that the AA induced in these Sprague-Dawley 
rats was not of a very severe nature.
4.1.7 Effect of 2-ME and ConA on the proliferative response 
of rat LNC during D-Pen treatment of AA
Oral D-Pen treatment (50 mg.Kg.”^day” )̂ of rat with AA 
modified the pattern of proliferative responses of LNC as 
shown in Fig. 4.4.d. The initial increase in proliferative 
response on day 2 of disease was significantly reduced (P < 
0.01), and the marked inhibition of the proliferative response 
to ConA (5 pg.ml.” )̂ on day 14 was reverted to an enhanced 
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proliferative response of 
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orally) AA induced in male Sprague- 
Dawley rats (n = 6, at each time 
interval). The results are expressed 
as mean + 1 s.d. (Statistical
analysis: Mann-Whitney U test).
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response decayed below the D-Pen treated normal level. The 
addition of 2-ME (5 x 10“^M) stimulated a significant increase 
in response at day 7 (P < 0.01) and day 21 (P < 0.01) when 
compared with that of D-Pen treated normal. 2-ME was found to 
enhance the ConA stimulated response of D-Pen treated AA rat 
LNC to above the D-Pen treated normal control level from days 
7 to 21 (P < 0.01, at all times intervals) although a slight 
drop in response occurred at day 2 of disease.
4.1.8 Proliferative response of normal and D-Pen treated 
normal rat LNC
The results presented in Table 11 show that short-term D-Pen 
treatment (50 mg.Kg.”^day” ,̂ orally for 7 days) of normal 
Sprague-Dawley rats produced no significant effect on the 
proliferative response of the unstimulated LNC. The addition 
of 2-ME (5 X 10”^M) induced a significant decrease in the 
proliferative response of D-Pen treated AA rat LNC (P < 0.05, 
Mann-Whitney U test) although the ConA (5 jig.ml.~̂ ) stimulated 
response showed an increase. The combined effects of 2-ME + 
ConA stimulated an enhancment of proliferative response that 
was significantly greater in D-Pen treated normal rat LNC than 
the untreated normal rat LNC (P < 0.05, Mann-Whitney U test).
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ADDITION NO TREATMENT D-PEN TREATMENT (7 days)
0 147 ± 13 136 ± 54
2-ME 755 ±  94 368 ± 169
ConA 1612 ±  244 2240 ±  693
2-ME + ConA 14962 ±  1880 18990 ±3 91 9
TABLE 11. The effects of 2-ME (SxlÔ M), Con A (Spg mM) 
and 2-ME + Con A on the proliferative responses 
of normal and D-PEN treated (50 mg.Kg."̂  orally, 
for 7 days) normal Sprague-Dawley rat LNC. The 
results are expressed as mean t 1 s.d.
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4.1.9 The effect of indomethacin on the proliferative 
response of rat SC and LNC in culture
Prostaglandins (PCs) are established mediators of inflammatory 
responses and have been long suspected to play an important 
role in articular destruction (Zvaifler, 1973, Ziff, 1982). 
In addition they suppress certain in vitro immune functions, 
including mitogen proliferative responses and IL-2 synthesis 
(Goodwin and Webb, 1980; Rappaport and Dodge, 1982). By 
blocking PG synthesis with indomethacin suppression of the 
proliferative response may be removed. Hence, the blockade of 
PG synthesis with indomethacin was investigated in the male 
Sprague-Dawley rat SC and LNC culture system.
The solvent for indomethacin is ethanol. Before examining the 
effect of indomethacin, the effect of ethanol on the 
proliferative response of rat SC and LNC must be established. 
For ethanol, a structural analogue of 2-ME might be mitogenic.
As Figs. 4.5(a) and (b) show, the addition of ethanol (4.8 x 
10” %̂) did not have any effect on the rat SC and LNC basal 
proliferative responses as well as those stimulated by 2-ME (5 
X 10~^M) ConA (5 pg.ml."^) and 2-ME + ConA.
The results of Figs. 4.5(a) and (b) also indicate that 
treatment of normal Sprague-Dawley rat SC and LNC in vitro 
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Fig. 4.5
(a), (b)
The effects of Ethanol (4.8 x 10 %)_,
Indomethacin (10 M), 2-ME (5 x 10
^M) and ConA (5 pg.ml.'^J on the 
proliferative response of normal male 
Sprague-Dawley rat (a) SC (n = 3) and 
(b) LNC (n = 3) in culture. The 
results are expressed as mean + 1 
s.d.
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proliferative responses of these cells stimulated or not 
stimulated with 2-ME (5 x 10~^M), ConA (5 pg.ml.” )̂ and 2-ME + 
ConA. Hence PCs did not appear to play any significant role 
in the system.
4.2 The effect of PHMPSA on the proliferative response of 
rat SC and LNC in culture
It has been demonstrated that the addition of SH blocking 
agents to cell cultures results in the inhibition of lectin- 
induced proliferation (Chaplin and Wedner, 1978). Experiments 
were carried out to determine whether this inhibition was due 
to blockade of cell surface SH groups.
Figs. 4.5.1(a) and (b) show that blocking the cell surface SH 
groups of SC and LNC by incubation with the non-penetrating SH 
blocking agent, PHMPSA (5 x lO'^M), resulted in the inhibition 
of the proliferative responses of these cells to 2-ME (5 x 10” 
M̂), ConA (5 |jg.ml.~̂ ) and 2-ME + ConA.
4.2.1 Effect of indomethacin on the proliferative responses 
of AA rat (a) SC and (b) LNC in culture
Figs. 4.6(a) and (b) also show that indomethacin (10”^M) did 
not restore the arthritic cells to normal indicating that PCs 
did not play a major part in contributing to the depressed 
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on the proliferative response of 
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EthanolThe effects of e n  
Indomethacin (10 ®M),
(4.8 X
2-ME (5 X 10 
M) and ConA (5 pg.ml.~l) on the 
proliferative response of AA (day 14) 
Sprague-Dawley rat (a) SC (n = 3) and 
(b) LNC (n = 3) in culture. The 
results are expressed as mean + 1 
s.d.
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As Figs. 4.6(a) and (b) show, ethanol (48 x 10 %̂) did not 
have any mitogenic activity on the basal proliferative 
responses as well as those stimulated with 2-ME (5 x 10"*̂ M), 
ConA (5 pg.ml.~l), and 2-ME + ConA. The 2-ME and ConA 
stimulated proliferative responses of both AA SC and LNC were 
depressed when compared with those seen in the normal rat 
(Figs. 4.5(a) and (b)). The mutual effects of 2-ME + ConA, 
however, appeared to enhance the proliferative responses of 
both the AA rat SC and LNC to above those seen in the normal 
rat. The background AA rat SC and LNC proliferative responses 
showed little difference from those of the normal rat.
4.2.2 Effect of PHMPSA on the proliferative responses of AA 
rat (a) SC and (b) LNC in culture
The results in Figs. 4.6.1(a) and (b) show that blocking the 
cell surface SH groups of AA rat SC and LNC with PHMPSA (5 x 
10“^M) inhibited all the proliferative responses stimulated 
with 2-ME (5 x 10~^M), ConA (5 pg.ml.” )̂ and 2-ME + ConA.
Again, ethanol (4.8 x 10~^%) was found to exert no mitogenic 
effect on the proliferative responses of D-Pen treated AA rat 
SC and LNC stimulated or not stimulated with 2-ME (5 x 10“ M̂), 
ConA (5 pg.ml.” )̂ and 2-ME + ConA as shown in Figs. 4.7(a) and 
(b). The depressed ConA stimulated proliferative responses 
seen in the AA rat SC and LNC were restored by in vivo D-Pen 
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Fig. 4.6.1. The effect of PHMPSA (5 x 10 ^M), 2- 
(a), (b) ME and ConA on the proliferative
response of AA (day 14) male Sprague- 
Dawley rats (a) SC (n = 3) and (b) 
LNC ( n = 3) in culture. The results 




I I No Aadition
I^ E th an o l
^ ^ In d o m eth ac in





control 2 -M E  ConA 2 -ME+ConA
Fig. 4.7
(a), (b)
The effects of Ethanol (4.8 x 10 
Indomethacin (10~®M), 2-ME (5 x 10 
^M) and ConA (5 pq.ml."^) on the 
proliferative response of D-Pen 
treated AA (day 14) Sprague-Dawley 
rat (a) SC (n = 3) and (b) LNC (n = 
3) in culture. The ̂ results are 
expressed as mean + 1 s.d.
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stimulated response of D-Pen treated AA rat SC was lower than 
those of both the normal rat and AA rat. The 2-ME stimulated 
LNC response, however, showed a slightly depressed level 
compared with that of the normal rat LNC although it was 
slightly higher than that of the AA rat LNC. The 2-ME + ConA 
stimulated responses of D-Pen treated AA rat SC and LNC were 
greater than those seen in the normal SC and LNC although 
showed no difference when compared with those of the AA rat SC 
and LNC. No difference was found between the background 
proliferative responses of normal, AA and D-Pen treated AA rat 
SC and LNC.
Figs. 4.7.1(a) and (b) indicate that blockade of cell surface 
SH groups of D-Pen treated AA rat SC and LNC with PHMPSA (5 x 
10 ^M) depressed all the proliferative responses stimulated 
with 2-ME (5 x 10~^M), ConA (5 pg.ml.” )̂ and 2-ME + ConA. The 
2-ME + ConA stimulated responses of D-Pen treated AA rat SC 
and LNC were not inhibited to the extent seen in those of 
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Fig. 4.7.1. The effect of PHMPSA (5 x 10“^M), 2- 
(a), (b) ME (5 X 10“^M) and ConA (5 
Mg.ml.”^) on the proliferative 
response of D-Pen treated AA (day 14) 
male Sprague-Dawley rats (a) SC (n = 
3) and (b) LNC ( n = 3) in culture. 
The results are expressed as mean + 1 
s.d.
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CHAPTER FIVE: RESULT C
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RESULT C: EFFECTS OF 2-MERCAFTOETHANOL AND D-PENldLLAMINE
ON INTERLEUKINS SYNTHESIS OF RATS WITH ADJUVANT 
ARTHRITIS
5.1 Interleukins
IL-1 is a derived mediator whose properties suggest that it 
can play a role in the pathology of arthritis. Activated m/6s 
release IL-1 which acts on T-lymphocytes to stimulate the 
production of IL-2 which in turn induces T-cell proliferation. 
Recently, the production of IL-2 was found to decrease in 
patients with RA (Alcocer-Varela et al., 1984; Combe et al., 
1985).
The aim of the present investigation was to test (1) if IL-1 
production by the LPS-activated peritoneal m^s and IL-2 
production by the spleen cells were altered during disease 
development of AA in male Sprague-Dawley rats and (2) whether 
in vivo D-Pen treatment of these AA rats could affect the 
production of IL-1 and IL-2 under these conditions.
5.1.1 IL-1 production during disease development of AA in 
Sprague-Dawley rats
Fig. 5.1.a shows the IL-1 synthesis by LPS-stimulated 
peritoneal m/z$s obtained from male Sprague-Dawley rats during 
the course of AA. IL-1 secretion by AA rat peritoneal mjz$s was
— 150 —
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Fig . 5 .1 .a. IL-1 production during disease 
development of AA in male Sprague- 
Dawley rats (n = 6, at each time 
interval). The results are expressed 
as mean + 1 s.d. (The s.d. bars are 
omitted for clarity). (Statistical 
analysis: Mann-Whitney U test).
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slightly reduced at day 4. However, at day 10 of disease the 
AA rat peritoneal m/̂ s released a significantly higher level of 
IL-1 than the normal control rat peritoneal m^s (P < 0.01). 
The level of IL-1 production by the AA rat peritoneal m^s was 
still higher (although not significantly) at day 17 of 
disease. Preincubation of these peritoneal mjz$s with 2-ME (5 x 
10~^M) and the cell surface SH blocker, PHMPSA (5 x 10”^M) did 
not alter the pattern of IL-1 synthesis by these cells. Both 
the normal and AA rat peritoneal mjẑs not stimulated with LPS 
(1 jig.ml.” )̂ produced little or minimal amount of IL-1. 
Again, preincubation of both the normal and AA rat peritoneal 
mç6s (not stimulated with LPS) with 2-ME (5 x 10”^M) and PHMPSA 
(5 X lO^^M) did not have any effect on the IL-1 production. 
This experiment shows that IL-1 production by both normal and 
AA rat peritoneal m;6s was not SH-dependent.
5.1.2 Effect of D-Pen treatment on IL-1 production during the 
course of AA in Sprague-Dawley rats
As Fig. S.l.b shows a high level of IL-1 was produced by the 
in vivo D-Pen treated (50 mg.Kg.”^day.“  ̂ for 7 days before 
induction of disease) normal rat peritoneal m^s stimulated 
with LPS (1 pg.ml.“ )̂. IL-1 synthesis by D-Pen treated AA 
peritoneal mĵ s began to decline from day 4 of disease and 
became significantly lower than that produced by D-Pen treated 
normal rat peritoneal m/z5s at day 17 (P < 0.05). 2-ME (5 x 10” 



















Fig. S.l.b. Effect, of D-Pen treatment (50 mg .Kg.” 
^day” ,̂ orally) on IL-1 production 
during the course of AA in male 
Sprague-Dawley rats (n = 6, at each 
time interval). The results are 
expressed as mean + 1 s.d. (The s.d. 
bars are omitted for clarity). 
(Statistical analysis: Mann-Whitney U 
test).
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of IL-1 production in this system. Little or minimal level of 
IL-1 synthesis was again observed with both the D-Pen treated 
normal and D-Pen treated AA rat peritoneal mg(s not stimulated 
woth LPS (1 |jg.ml.~̂ ). Preincubaion of these peritoneal mĝ s 
not stimulated with LPS with 2-ME (5 x 10~^M) and PHMPSA (5 x 
10”"̂ M) did not affect the IL-1 production. Again, this 
demonstrates that the IL-1 production in the rat system was 
not SH-dependent.
5.1.3 IL-1 production by peritoneal mgJs from AA rat and 
D-Pen treated AA rat
Fig. 5.1.C shows that the in vivo D-Pen treatment (50 mg. 
Kg.“^.day”  ̂for 7 days) appeared to enhance the IL-1 synthesis 
by LPS-stimulated peritoneal mĝ s in normal rats. IL-1 
production was decreased in both the AA and D-Pen treated AA 
rats (more markedly in D-Pen treated AA rats) at day 4 of 
disease. However, D-Pen treatment depressed the high level of 
IL-1 synthesis on day 10 of AA (P < 0.01). IL-1 synthesis by 
AA peritoneal m/z$s decreased to the normal control level at day 
17. D-Pen treatment further depressed this reduced IL-1 
secretion by AA rat peritoneal mgJs at day 17 of disease (P < 
0.01).
5.1.4 Screening for IL-2 activity in the IL-1 supernatant 
















Fig. 5.I.C. IL-1 production by AA rats and D-Pen 
treated (50 mg.Kg.”^day” ,̂ orally) AA 
rats (n = 6/ at each time interval 
for both groups of rat). The results 
are expressed as mean + 1 s.d.
(Statistical analysis: Mann-Whitney U 
test).
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promote the synthesis of IL-2 which in turn induces T-cell 
proliferation. As the IL-1 assay used in this study was not 
specific it would also detect IL-2 activity. Hence, IL-1 
supernatants (obtained from normal, D-Pen treated normal, AA 
and D-Pen treated AA rat peritoneal m^s through activation 
with 1 pg.ml.”  ̂LPS) were also screened for IL-2 activity. 
All these results proved negative (results not shown).
5.2 IL-2 production during disease development of AA in 
Sprague-Dawley rats
Fig. 5.2.a shows that a decreased level of IL-2 was produced 
by the ConA (20 pg.ml."^)-stimulated SC during the course of 
AA in male Sprague-Dawley rats. A significant decrease in IL- 
2 synthesis by the AA rat spleen cells occurred at day 4 of 
disease (P < 0.01). Although IL-2 production appeared to 
increase at day 10 of disease it began to decline again over 
the next 7 days. IL-2 production at day 10 and day 17 
respectively, was lower than the normal control level 
(although not significantly). Preincubation of SC with 2-ME 
(5 X 10~^M) or PHMPSA (5 x 10~^M) did not affect the extent of 
IL-2 production. Thus, IL-2 production was not SH-dependent. 
Splenocytes of both the normal and AA rats not stimulated by 
ConA (20 |ig.ml.“ )̂ produced minimal amount of IL-2.
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Fig . 5 .2 .a. IL-2 production during disease 
developme of AA in male Sprague- 
Dawley ra^s (n = S, per time point). 
The results ^re expressed as mean + 1 
s.d. (The s.d. bars are omitted for 
clarity). (Statistical analysis; 
Mann-Whitney U test).
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5.2.1 Effect of D-Pen treatment on IL-2 production during the 
course of AA in Sprague-Dawley rats
The results of Fig. 5.2.b show that in vivo D-Pen treatment 
(50 mg.Kg.“^.day” r̂ orally) of AA did not affect the IL-2 
synthesis by the ConA (20 ^ig.ml."^)-stimulated SC during the 
course of AA. In vivo D-Pen treatment also did not alter the 
IL-2 production by normal rat SC. Preincubation with 2-ME (5 
X 10~^M) or PHMPSA (5 x 10”^M) did not alter the IL-2 
synthesis by the SC obtained from both the D-Pen treated 
normal and D-Pen treated AA rats. This shows that IL-2 
production in this system was not SH-dependent. SC of normalr 
AA and D-Pen treated AA rats not stimulated with ConA (20 
[jg.ml.” )̂ release minimal amount of IL-2.
5.2.2 IL-2 production by SC from AA rats and D-Pen treated AA
rats
The results in Fig. 5.2.C show that the in vivo D-Pen 
treatment (50 mg.Kg.”^.day"^, orally for 7 days) decreased the 
IL-2 synthesis by the normal rat SC. Although in vivo D-Pen 
treatment appeared to increase the low IL-2 synthesis at day 4 
of disease to the D-Pen treated normal control level, it had 
no effect on the IL-2 synthesis by the AA rat SC at day 10 and 
day 17.
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Fig . 5 .2 .b . The effect of D-Pen treatment (50 
mg.Kg.“^day” , orally) on IL-2 
production during the course of AA in 
male Sprague-Dawley rats (n = 6, at 
each time point). The results are 
expressed as mean + 1 s.d. (The s.d. 
bars are omitted for clarity). 
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Fig. 5.2.C. IL-2 production by AA rats and D-Pen 
treated (50 mg.Kg. ^day” ,̂ orally) AA 
rats (n = 6, at each time point for 
both groups). The results are 
expressed as mean _+ 1 s.d.





Using DTNB as a reagent, the spectophotometric method for the 
determination of both the total serum protein SH level and 
reactivity is simple and convenient. Normal humans were found 
to have a mean total serum SH level of 538pmoles/l. This 
confirms the finding of Lorber et al. (1964) who reported that 
the SH content of normal human serum is stable and rarely 
fluctuates outside the 400-600 pmoles/1. range. The mean SH 
level of normal human serum is significantly higher than that 
of rabbit, guinea-pig, rat and mouse. The change in 
absorbance at 440 nm. during the first minute of SH-SS 
exchange reaction between DTNB and serum protein SH groups 
varied considerably between individual samples. This initial 
rapid reactivity represents partly the interaction of low 
molecular (non-protein) thiols with DTNB (Jocelyn, 1962). The 
increase in absorbance during the second minute (between 1 and 
2 minutes) of the SH-SS exchange reaction appeared linear and 
hence more accurate and consistent data could be obtained. 
This finding is in line with the observation made by Butler et 
al. (1969) who found that the change in optical density 
between 1 and 2 minutes was strictly linear. It is 
interesting to find that although the mean total serum protein 
SH level of the rat is significantly lower than that of the 
mouse, its serum SH reactivity is significantly faster in the 
first minute of the SH-SS exchange reaction, although there is 
no difference in the second minute of the reaction. Indeed, 
the serum SH reactivity of the rat is significantly faster 
than that of any other animal species studied. The rat serum
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SH reactivity is 7 times faster than that of the human in the 
first minute and 4 times faster in the second minute of 
reaction. This finding also agrees with the observation of 
Butler et al. (1969) that rat serum exhibits a much more rapid 
rate of reaction with DTNB than human serum. The fast 
reaction rate of the rat serum may indicate that serum from 
these animals contains more low molecular weight thiols which 
would catalyse the SH-SS exchange reaction. It may also be 
the case that the serum protein SH groups of rat are more 
reactive and sensitive to oxidation than those of the human. 
This would imply that the conformation of the albumin 
molecules in rat serum differs from that in man, the free SH 
group presumably being more accessible to oxidation and to 
reaction with DTNB. This suggestion would explain the low 
total SH levels and high SH reactivity observed with rat 
serum. Freezing was found to depress the serum protein SH 
level and reactivity of the various animal species studied. 
This supports the observations made by various investigators 
(Lorber et al., 1964; Butler et al., 1969; Hall and Gillan, 
1979). The depressed serum protein SH level and reactivity 
observed with freezing may be due to the formation of 
disulphide dimers (via SH-SS exchange) between SH groups of 
the serum proteins present in the serum. The amounts of these 
dimers increase with storage leading to less free SH groups 
available for reaction with DTNB resulting in decreased SH 
level and reactivity.
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In the present study, changes in total serum protein SH levels 
were studied during the course of AA in rats. A depression of 
serum protein SH levels and reactivity was found in rats that 
developed AA and this was associated with the persistent 
chronic inflammatory phase of the disease. The major 
depression of serum SH and reactivity occurred at the time of 
onset of AA (i.e. between day 10 and day 17) although the 
change was noticeable as early as 2 days after AA induction. 
These results confirm the findings of other workers (Butler et 
al., 1969; Lorber et al., 1975; Barbier et al., 1984). 
According to Lorber et al. (1975) the depressed serum SH level 
observed in rat serum was not due to the acute inflammatory 
phase since those rats in which AA was suppressed by the 
competing antigen did not show any depression. Neither was 
the depression due to decreased food consumption or loss of 
body weight (Lorber et al., 1975). This depression may be 
caused by oxidative stress due to the production of oxidative 
species, especially H2O2 by activated phagocytes (Hall et al., 
1984) in the active inflammatory phase when gross tissue 
injury occurs. This may follow the same process as the 
finding of Thomas and Evans (1975) in rheumatoid patients. 
They showed that human serum SH levels are due almost entirely 
to cysteine side-chains within protein structures. The great 
majority of serum SH groups are present in albumin with the 
remainder distributed within the globulin fractions. The 
depression of serum SH in RA appears to be due to oxidation 
and subsequent mixed disulphide formation with a low molecular
- 164 -
weight thiol, cysteine, and with trace amounts of glutathione 
(Thomas and Evans, 1975).
Experiments with D-penicillamine treatment showed that 
although in vivo treatment with this SH-containing, second- 
line antirheumatic drug had no effect on the total serum 
protein SH level and reactivity of normal rats, it increased 
the serum SH level in AA rats towards normality over days 14- 
21. Furthermore, it also increased the serum SH reactivity 
towards normality by day 21 in the first minute reaction and 
by day 10 in the second minute measurement. This result 
suggests that D-penicillamine may act as a reducing agent, 
restoring the free SH groups that have been blocked in active 
AA via interaction with the mixed-disulphide formed from SH 
groups between albumin and other low molecular weight thiols 
due to oxidation caused by active inflammation. It must be 
stressed that although in vivo D-penicillamine treatment 
increased the AA serum SH reactivity to normal it did not 
stimulate the increase in SH reactivity significantly faster 
than that of normal serum as it does with RA serum SH 
reactivity as demonstrated by Hall and Gillan (1979). The 
difference may be due to (1) the pre-existence of more 
reactive low molecular weight thiols in AA rat serum than in 
RA serum and D-penicillamine treatment was no longer able to 
affect the fast reactivity of these reactive thiols, (2) the 
very much higher doses of D-penicillamine administered to AA 
rats than to RA patients. The increase in serum bound D-
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penicillamine in AA rats may lead to a slower rate of SH-SS 
exchange reaction due to steric hindrance and formation of 
mixed di sulphide with low molecular weight thiols. This is 
reminiscent of the dose-response profiles of 2-ME and ConA 
seen in mouse and rat spleen cell culture experiments where 
low doses lead to suboptimal proliferative responses and 
supraoptimal doses result in inhibition of responses.
The present study also showed that in vivo D-penicillamine 
treatment (50 mg./Kg./day, orally from day -7 to day +21) of 
AA had no effect on the various parameters used to evaluate 
disease severity (i.e. circumference of hind paws, weight 
change and arthritic score). These observations confirm the 
results of Liyanage and Currey (1972) who found that 200 
mg./Kg. D-penicillamine had no effect on AA in rats. Similar 
results were also obtained by Dunn et al. (1984) who showed 
that oral pretreatment (1 to 3 months) of AA rats with D- 
penicillamine (100 mg./Kg. p.o.) followed by daily treatment 
after AA induction failed to modify the different parameters 
used to assess arthritic scores. In some studies, D- 
pencillamine has been shown to exacerbate the secondary 
lesions of AA (Binderup et al., 1976).
Although D-penicillamine does not affect the clinical course 
of AA it might modify the cell functions in the rats perhaps 
through the SH groups. Therefore, lymphocyte functions were 
investigated in rats with or without AA in order to identify
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their SH dependence.
The addition of the simple low molecular weight thiol, 2-ME, 
to culture of both normal mouse and rat spleen cells resulted 
in a dramatic increase in uptake of [^H] thymidine. The 
increase was more pronounced in the mouse system. This 
phenomenon occurred in a dose-related fashion with the peak 
[%] thymidine incorporation at 5 x 10"% 2-ME. The shape of 
the dose-response curve of the T cell mitogen, ConA, is 
similar to that of 2-ME, with maximal [^H] thymidine uptake 
occurring at 5pg/ml. for both mouse and rat spleen cell 
cultures. In the mouse system, the addition of 2-ME to ConA 
stimulated spleen cell cultures produced only an additive 
response. However, in the rat system, the addition of 2-ME 
greatly enhanced the ConA stimulated proliferative response. 
The difference in the ConA stimulated spleen cell 
proliferative responses of these animals may be due to a 
difference in sensitivity of their surface SH groups to 
oxidation. The rat has a lower serum protein SH level than 
the mouse with a faster serum SH reactivity. This may reflect 
the more sensitive and reactive nature of the rat spleen cell 
surface SH groups to oxidation if it is assumed that the 
spleen cell surface thiols are equally susceptible to 
oxidation as serum SH groups. The ConA stimulated rat spleen 
cell surface SH groups oxidised quickly and became hyper- 
responsive to the presence of 2-ME in the culture medium thus 
giving rise to a much greater enhancement of response compared
- 167 -
with the mouse spleen cell response. The result also suggests 
that functionally free surface SH groups are needed for the 
rat spleen cells to proliferate and the addition of 
appropriate concentration of 2-ME to the cell culture helps 
maintain the cell surface SH groups in a reduced state.
Blockade of cell surface SH groups using the irreversible cell 
surface SH blocker, PHMPSA, abolished the ConA stimulated 
proliferative response. The addition of 2-ME to ConA 
stimulated cultures treated with PHMPSA could not reverse this 
inhibition. This result also indicates that cell surface 
thiols are necessary for proliferation of rat spleen and lymph 
node cells. This finding is in line with the observation of 
Chaplin and Wedner (1978) who demonstrated that blockade of 
free SH groups on human peripheral blood lymphocyte surface by 
diamide and other SH reagents led to an inhibition of lectin 
(PHA or ConA)-induced lymphocyte activation. The SH oxidising 
agent, diamide, was only effective when added within 30-60 
minutes of lectin. This inhibition of lymphocyte activation 
was not caused by decreased intracellular levels of reduced 
glutathione or by inhibition of binding of lectin to the 
lymphocyte (Chaplin and Wedner, 1978). These results suggest 
that maintenance of free SH groups is important during the 
early induction of lymphocyte activation and indicate that an 
obligatory step or steps in the activation sequence may 
involve SH interactions.
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Various mechanisms have been proposed to explain the dramatic 
effect of 2-ME on rat and mouse lymphocyte proliferation. 
Opitz et al. (1977) suggested that 2-ME does not act directly 
on lymphocytes, but it converts a native serum factor (Pro- 
MaSF) in the FCS into the activated serum factor (MaSF) that 
could elicit an antibody response to SRBC (Lemke and Opitz, 
1976), anti-IgM-induced murine B cell proliferation (Sidman 
and Unanue, 1978) and murine T lymphocyte proliferation 
(Opitz, 1978) without further addition of 2-ME. Hewlett 
(personal communication, 1981) postulated that the Pro-MaSF 
was albumin and MaSF mercaptalbumin. The addition of 2-ME 
reduced the albumin to mercaptalbumin, the active fraction for 
the induction of the immune response. This is supported by 
the finding of Smith et al. (1978) who showed that in the 
culture medium, thiols such as 2-ME appear to function by 
altering albumin. Hoffeld and Oppenheim (1980), however, 
postulated that a major role of 2-ME in augmenting antibody 
responses in vitro is to convert oxidised glutathione (GSSG) 
in the serum into reduced glutathione (GSH), protecting it 
from further oxidation and preventing the accumulation of 
GSSG, an inhibitory product, by interchange with it. Ohmori 
and Yamamoto (1983b) proposed a third possible explanation for 
the effect of 2-ME on lymphocyte activity. They suggested 
that a major role of 2-ME in the augmentation of antibody 
responses would be to stimulate the utilisation of cystine in 
both B cells and T cells through the formation of Cys-2-ME. 
Both cysteine and Cys-2-ME would promote cystine uptake in the
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initial phase of the culture. However, Cys-2-ME is more 
preferentially involved in the enhancement of cystine uptake 
throughout most of the culture period (4-5 days). Cys-2-ME 
itself could support the antibody response much more 
efficiently than cysteine. These workers also suggest that 2- 
ME is able to augment the antibody response because it has a 
durable stimulatory effect on cystine uptake. The superiority 
of 2-ME over other thiol compounds in its durable effect would 
be due to the fact that Cys-2-ME is also efficiently taken up 
by the lymphocytes. This would explain the observation that 
2-ME added 3 days before the start of the culture could 
augment the antibody response as efficiently as freshly added 
2-ME (Chen and Hirsch, 1972).
As discussed earlier, the addition of 2-ME to ConA stimulated 
rat spleen or lymph node cell cultures induced an enhancement 
of proliferative response and treatment of cells with PHMPSA 
abolished the 2-ME, ConA and 2-ME + ConA stimulated responses. 
These results suggest a fourth possibility, that the presence 
of cell surface SH groups is necessary for lymphocytes to 
proliferate, and that 2-ME maintains these SH groups in a 
reduced state. If this is the case, the role of MaSF (Opitz 
et al., 1977) present in the FCS-containing culture medium 
used for culturing rat spleen and lymph node cells in the 
present study might be as a reducing agent to restore the 
oxidised cell surface SH groups to that reduced state 
necessary for normal cell proliferative responses.
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As FCS is known to contain both cysteine and GSH the role of 
2-ME in promoting cell proliferation via a cystine uptake 
mechanism (Ohmori and Yamamato, 1983b) is a very plausible 
one. In the present study, 2-ME (5 x 10”^M) was added to the 
rat spleen or lymph node cell at the beginning of cultures and 
incubated for 3 days without further daily addition. Under 
these conditions, the added 2-ME would be present as the 
di sulphide form (2-hydroxyethyldi sulphide or 2-ME^^) and mixed 
di sulphide with FCS components, cysteine and GSH (Ohmori and 
Yamamato, 1983b). It is likely that 2-MEq^̂ and FCS-bound 2-ME 
could stimulate the uptake of cystine into the lymphocytes 
through the formation of Cys-2-ME. Cys-2-ME would then be 
readily metabolised to GSH and cysteine after uptake. It was 
observed that free thiol was generated when 2-ME^^ was 
incubated with the lymphocytes (Ohmori and Yamamato, 1983b). 
Therefore, it appears that the rat spleen and lymph node cells 
would reduce FCS-bound 2-ME and 2-ME^^ to liberate free 2-ME 
that reacts with cysteine to produce equimolar amounts of Cys- 
2-ME. The liberation of 2-ME from 2-ME-pulsed FCS might be 
mediated by a small amount of thiol compounds released from 
the cells (Ohmori and Yamamato, 1983b). Hence, 2-ME promotes 
lymphocyte proliferation by stimulating the utilisation of 
cystine, an essential amino acid in both B cells and T cells 
through the formation of Cys-2-ME. 2-ME that was transformed 
into FCS-bound and oxidised forms could be used for the 
formation of Cys-2-ME via interaction with the lymphocyte, 
liberating free thiol and this reaction would help to maintain
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the lymphocyte surface SH groups in a reduced state 
essentially for normal lymphocyte function.
The present study shows that induction of AA in Sprague-Dawley 
rats by the injection of heat-killed M. Tuberculosis in 
mineral oil led to an initial increase (at day 2) in the 
proliferative response of both the spleen and lymph node cells 
to ConA alone as measured by the incorporation of [^H] 
thymidine into cellular DNA. This initial increase in 
response was followed by marked inhibition of Ê H) thymidine 
incorporation in ConA stimulated spleen and lymph node cells 
14 days after the induction of disease. Thereafter, the 
response returned to control values. These results confirm 
the findings of others that spleen and lymph node cells from 
rats with active AA responded poorly in vitro to ConA 
(Arrigoni-Martelli and Binderup, 1981; Gilman et al., 1984). 
The return to normal of ConA stimulated spleen and lymph node 
cell proliferative response as early as day 21 indicates that 
the AA induced in the Sprague-Dawley rats was not of a very 
severe nature. The in vitro addition of 2-ME to the ConA 
stimulated AA rat spleen and lymph node cell cultures greatly 
enhanced the initial increase in Ê H] thymidine incorporation 
at day 2 to a level significantly higher than that of the 
normal control values. Furthermore, the presence of 2-ME was 
found to not only reverse but also enhance the markedly 
depressed ConA stimulated proliferative responses of AA rat 
spleen and lymph node cells (at day 14 of disease) to a level
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significantly higher than the normal control values with 2-ME 
+ ConA. The ConA stimulated spleen cell response was more 
markedly enhanced by 2-ME than the ConA stimulated lymph node 
cell response. The present experiment also shows that in vivo 
treatment with D-penicillamine during the course of AA 
modified the pattern of ConA stimulated proliferative response 
of AA rat spleen and lymph node cells. The results show that 
the initial increase in proliferative response of both ConA 
stimulated AA rat spleen and lymph node cells at day 2 of 
disease was significantly reduced and the marked inhibition of 
proliferative response to ConA at day 14 was reverted to an 
enhanced response to ConA compared with cultures from 
untreated arthritic rats and nonarthritic rats. The addition 
of 2-ME in vitro to the ConA stimulated cultures of the D- 
penicillamine treated AA rat spleen and lymph node cells 
further enhanced the already increased proliferative responses 
due to D-penicillamine treatment alone. The markedly enhanced 
ConA stimulated responses by 2-ME were still rising at day 21 
of disease although in the respective AA rat, the 2-ME + ConA 
responses were back at normal control level at day 21. Again, 
the proliferative response of ConA stimulated D-penicillamine 
treated rat spleen cells was more markedly enhanced by 2-ME 
than that of the matched lymph node cells. This difference 
may be attributed to the existence of different subpopulations 
of lymphocytes in the lymphoid organs that express different 
responsiveness to 2-ME in their response to ConA. In the rat 
lymph nodes, about 30 to 40% are B cells, the remainder T
- 173 -
cells. In spleen, 60% B, 40% T (Gordon Van Arman, 1976). 
According to Goodman and Weigle (1977) mouse spleen B cells 
are much more 2-ME responsive than T cells. Assuming the rat 
B cells obtained from spleen or lymph node are equally 2-ME 
responsive as the mouse spleen B cells, it is quite obvious 
that the rat spleen cells containing 60% B cells should 
respond more markedly to 2-ME than the rat lymph node cells 
which contain only 30-40% B cells. Alternatively, the more 
marked spleen cell response may be related to the spleen cell 
sensitivity to suppressive mechanisms from macrophages or due 
to oxidative activity generated by activated phagocytes in 
active AA. The spleen cells may become hyper-reactive to 2-ME 
in vitro and D-penicillamine in vivo.
In vivo D-penicillamine treatment (50 mg./Kg./day, orally, for 
7 days) of normal Sprague-Dawley rats did not increase the 
unstimulated incorporation of [%] thymidine into spleen and 
lymph node cells. This result is in contrast with that of 
Arrigoni-Martelli and Binderup (1981) who found that a short­
term treatment with D-penicillamine (50 mg./Kg./day, orally, 
for 4 days) of normal Lewis rats increased the unstimulated 
incorporation of [̂ H] thymidine into lymph node lymphocytes. 
However, the result presented shows that D-penicillamine 
treatment did increase the ConA stimulated proliferative 
response of both the AA rat spleen and lymph node cells 
compared with the respective controls. This confirms the 
result of Binderup et al. (1980) who also found that
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administration of D-penicillamine (50 mg./Kg./day for 4 days) 
increased the uptake of [^H] thymidine in ConA stimulated 
lymph node and spleen cells from Lewis rats. They suggested 
that D-penicillamine treatment in vivo enhances the 
responsiveness of lymphocytes dependent on the presence of 
functionally intact macrophages. The lymphocytes in D- 
penicillamine treated rats may have been primed in vivo by 
macrophages to an increased responsiveness such that the 
presence of adherent cells in vitro is no longer required for 
a response (Binderup et al., 1980; Arrigoni-Martelli and 
Binderup, 1981).
The altered cell functions of AA rats found in the present 
study may be due, at least in part, to the functional free 
cell surface SH groups of both the spleen and lymph node cells 
being oxidised (blocked). This is suggested by the serum 
protein SH level and reactivity of these AA rats also being 
markedly depressed at day 14 of disease and the addition of 2- 
ME in vitro and D-penicillamine treatment in vivo reversing 
and enhancing the markedly inhibited ConA stimulated 
responses. In addition, the reduced AA cell proliferative 
responses to ConA could be attributed to suppression from 
activated macrophages (Arrigoni-Martelli and Binderup, 1981) 
via a mechanism involving SH groups (see below). Removal of 
adherent cells or elimination of macrophages with the 
selective macrophage toxin, silica, abolished the inhibited 
proliferative responses at day 14 of disease (Arrigoni-
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Mar tel1i and Binderup, 1981). The production of 
prostaglandins by activated macrophages may also cause the 
altered cell functions since prostaglandins can suppress 
certain in vitro immune functions including mitogen stimulated 
proliferative responses (Goodwin and Webb, 1980). The 
macrophages from AA rats may thus exert their suppressive 
activity via release of inhibitory prostaglandins into the 
culture medium. By blocking prostaglandin synthesis the 
suppression of proliferative response may be removed. Hence, 
blockade of prostaglandin synthesis using indomethacin was 
investigated. The addition of indomethacin, however, did not 
abolish the observed inhibition of proliferative responses in 
AA rat spleen and lymph node cells. This result indicates 
that prostaglandin synthesis did not play a significant role 
in mediating the observed depression of proliferative 
responses of AA rat cells to ConA. The macrophages may exert 
their suppressive effects via other mechanisms. Binderup 
(1983 a, b) found that the function of macrophages was altered 
during the course of AA. Suppressor macrophages were found in 
the spleen and lymph node shortly after the induction of 
disease, these cells could inhibit lymphocyte responses to 
both B and T mitogens. Similar findings were reported by 
Gilman et al. (1985) who found that arthritic rat cells are 
not inherently hyporesponsive but the adherent suppressor 
cells were actively inhibiting T cell reactivity perhaps 
through the release of a soluble suppressor factor. Also, 
Aune and Pierce (1982) found that in the mouse system, ConA
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stimulated murine T suppressor cells act via the mediator, 
soluble immune response suppressor (SIRS) which can 
nonspecifically suppress proliferative responses to 
alloantigen and mitogens in vitro. The target of SIRS is the 
macrophage. Incubation of macrophages with SIRS induces the 
release of macrophage derived suppressor factor (M/jS-SF), which 
is directly responsible for the observed suppression of 
responses. Mj6-SF can also be obtained by reacting SIRS with 
low concentrations of H2O2 in the absence of macrophages. 
Thus, macrophages may serve as a source of H2O2 and the 
mechanism of Mjz$-SF action appears to have an oxidative basis 
(Aune and Pierce, 1982). M^-SF is lost following treatment 
with SH reagents such as 2-ME, dithiothreitol or cysteine. 
Furthermore, M^-SF mediated inhibition can be reversed by high 
concentration of 2-ME or dithiothreitol under appropriate 
conditions (Aune and Pierce, 1982). It may well be that the 
induction of AA activates the macrophages to release H2O2 
which reacts with SIRS to induce formation of M^-SF which in 
turn suppresses the ConA stimulated proliferative response of 
AA rat spleen and lymph node cells at day 14 of disease. 
Alternatively, during active AA in rats the macrophages 
present in the spleen and lymph nodes may become defective 
(due to cell surface free SH groups being blocked or oxidised) 
in presenting the mitogen (ConA) to the lymphocytes for a 
normal immune response to occur. However, the work of McKeown 
(1984) (PhD thesis, data unpublished) with rat lymph node 
cells showed that removal of adherent cells by passage down a
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Sephadex G-10 column abolished antigen stimulated lymphocyte 
proliferation. The proliferative response could only be 
recovered with added macrophages in the presence of 2-ME and 
not by preincubation of cells with 2-ME. There was no 
significant difference in lymph node cell proliferation 
whether macrophages were pulsed with antigen in the presence 
or absence of 2-ME (McKeown, 1984). These results show that 
the presence of free SH groups on macrophages are not 
obligatory for antigen presentation. Arrigoni-Martelli and 
Binderup (1981) showed that the altered cell function in AA 
may also be associated with a decrease in T helper cell 
activity at day 14 in cultures from untreated AA rats. This 
decrease was dependent on the presence of suppressor 
macrophages and was not observed in the corresponding cultures 
from D-penicillamine treated AA rats (Arrigoni-Martelli and 
Binderup, 1981). Hence, treatment with D-penicillamine 
in vivo may inhibit macrophage-mediated suppression, thereby 
permitting more effective T and B effector cell function. The 
increased T helper cell activity following D-penicillamine 
treatment may, through the production of lymphokines, activate 
macrophage clearance functions (Arrigoni-Martelli and 
Binderup, 1981) thus removing the macrophage-mediated 
suppression. The addition of 2-ME in vitro may inactivate the 
M|z$-SF mediated inhibition. In vivo D-penicillamine treatment 
may prevent the generation of activated macrophages or 
alternatively it may inhibit the release of H2O2 by activated 
macrophages. Either one mechanism will lead to normalisation
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of cell function because H2O2 is not secreted for reacting 
with SIRS to activate M^-SF, resulting in depressed cell 
functions. D-penicillamine may also act by directly 
inactivating M/zJ-SF in the same way as 2-ME.
Because T cell proliferation in vitro is dependent on the 
production and utilisation of IL-1 and IL-2 (Smith, 1980; 
Dinarello, 1984) the possibility was examined that an 
imbalance in the regulation of this lymphokine cascade system 
could contribute to the depressed immune function in arthritic 
rats. In response to LPS the production of IL-1 by peritoneal 
macrophages from rats with AA was slightly reduced at day 4 
followed by a significant increase at day 10. This may be due 
to the macrophages becoming highly activated in the process of 
developing an active inflammatory response (i.e. at day 10) 
before the rats became arthritic at day 14. The level of IL-1 
synthesis was still higher than that of the normal control 
value at day 17 (the time when rats became arthritic). This 
observation is in line with the result of Gilman et al. (1984) 
who found that the synthesis of IL-1 by splenic or peritoneal 
macrophages from arthritic rats equalled or exceeded that of 
macrophages obtained from normal rats. Interestingly, 
rheumatoid monocytes, when stimulated with LPS, also produced 
enhanced amount of IL-1 compared with controls (McKeown et 
al., 1984). Thus, the proliferative defects of AA cells could 
not be accounted for by the insufficient availability of IL-1. 
However, the proliferative response of spleen cells from
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arthritic rats to IL-1 was found to be markedly reduced 
(Gilman et al., 1985). This reduced AA rat spleen cell 
response may be caused by defective expression of IL-1 
receptors by the arthritic rat spleen T lymphocytes which may 
be thiol dependent, and if the arthritic rat spleen cell 
surface SH groups are blocked, this may also result in 
defective expression of IL-2 receptors. The experiments of D- 
penicillamine treatment on IL-1 synthesis shows that D- 
penicillamine treatment in vivo decreased the production of 
IL-1 during the course of AA in Sprague-Dawley rats. This 
result suggests that D-penicillamine may act by partially 
preventing the activated macrophages from releasing large 
amounts of IL-1 thus preventing tissue damage mediated by this 
factor. Alternatively, D-penicillamine may act to prevent the 
generation of activated macrophages and thereby reduce the 
amount of IL-1 being produced. This would support the 
activated macrophage -> H2O2 -> SIRS -> M^-SF hypothesis 
leading to altered cell function (see Fig. 6). D - 
penicillamine treatment of normal rats led to a high level of 
IL-1 being produced by LPS-stimulated peritoneal macrophages. 
The synthesis of IL-1 was not SH dependent as treatment with 
either 2-ME or PHMPSA did not affect IL-1 production by LPS- 
stimulated peritoneal macrophages from normal, D-penicillamine 
treated, normal untreated AA and D-pencillamine treated AA 
rats. Minimal amounts of IL-1 were produced by rat peritoneal 
macrophages not stimulated with LPS. The results of IL-2 
production experiments show that a decreased amount of IL-2
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was produced by ConA stimulated spleen cells during the course 
of AA in Sprague-Dawley rats. A significant decrease in IL-2 
production occurred at day 4 of disease. Although the IL-2 
production appeared to increase at day 10 it began to decline 
again at day 17. IL-2 production at day 10 and day 17, 
respectively, was lower than the normal control level 
(although not significantly). This result is less marked than 
the findings of Gilman et al. (1984) who reported that spleen 
cells from arthritic rats produced significantly reduced 
amounts of IL-2 following stimulation with ConA or PHA. Could 
this observation be the explanation for the reduced ConA 
stimulated AA rat spleen periferative response seen at day 14 
of disease? According to Gilman et al. (1984), the reduced 
IL-2 production is not physiologically relevant, since 
bypassing the IL-2 synthetic defect by supplying an exogenous 
source of IL-2 did not restore their proliferative capacity. 
Furthermore, ConA stimulated spleen cells from AA rats failed 
to bind IL-2 or respond to this factor with increased [^H] 
thymidine incorporation as did normal cells (Gilman et al., 
1984). Thus, it could be that the principal defect in AA 
spleen cells is the failure to produce receptors for IL-2 and 
thereby receive the IL-2 mediated growth signal. Detailed 
analysis of IL-2 receptors using monoclonal antibody to the 
rat IL-2 receptor (for example, the human anti-Tac equivalent 
(Robb and Greene, 1983)) should throw light on this. The 
expression of IL-2 receptor may also be thiol dependent. The 
blocked surface SH groups on arthritic rat spleen cells may
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lead to the failure of IL-2 receptor expression. D- 
penicillamine treatment did not affect IL-2 production by ConA 
stimulated spleen cells during the course of AA. In addition, 
D-penicillamine treatment did not alter the IL-2 synthesis by 
normal rat spleen cells. The production of IL-2 was not thiol 
dependent since treatment with either 2-ME or PHMPSA did not 
affect the IL-2 synthesis by ConA stimulated spleen cells 
obtained from the normal, D-penicillamine treated normal, 
untreated and D-penicillamine treated AA rats. Spleen cells 
obtained from normal, untreated AA and D-penicillamine treated 
AA rats not stimulated by ConA released only minimal amounts 
of IL-2.
The depressed spleen and lymph node cell responsiveness in AA 
rats is not simply a consequence of exposure of the animals to 
M. butyricum but is in fact related to the development of an 
arthritic response since spleen cell reactivity is normal in 
M. butyricum injected animal which failed to develop arthritis 
(Gilman et al., 1984).
From the data discussed so far, it appears that the altered 
cell functions in AA rats may represent the result of the 
interactions of a series of complex immunological events that 
occur during the development of an arthritic response 
initiated by the injection of CFA.
With these considerations in mind, a hypothetical scheme is
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presented in Fig. 6 to account for the series of immunological 
events that lead to the altered cell functions in AA. 
According to this scheme, the mycobacterial material is 
considered to be playing a dual role in the induction of 
chronic arthritis in genetically predisposed strains of rats 
(e.g. Sprague-Dawley rats). First, the mycobacteria attract 
large numbers of leucocytes to the site of injection and to 
visceral loci, with subsequent release of proteolytic enzymes 
and an increase in hydrogen ion concentration at the extra 
cellular foci producing a granuloma with active inflammation. 
At the same time, mycobacterial cell wall materials enhance 
the immune response by activating macrophages. The activated 
macrophages may (1) release an increased amount of IL-1 and 
prostaglandins leading to further inflammatory events; (2) 
produce several active oxidative species including H2O2 
causing further tissue damage. The H2O2 thus produced may 
also react with SIRS to form M^-SF which may then interact 
with spleen cells or lymph node cells to cause inhibition of 
proliferative responses to ConA, (3) react directly with SIRS 
to suppress the proliferative responses to ConA; and (4) 
release other soluble suppressive factor(s) that can act on 
the AA rat lymphocytes to suppress the proliferative response 
to ConA. The failure of the spleen (or lymph node) cells to 
produce IL-1 and IL-2 receptors possibly due to blocked cell 
surface SH groups may also lead to the depressed ConA 
stimulated cell proliferative responses seen in AA.
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The most likely conclusion of this work is that the addition 
of 2-ME in vitro and D-penicillamine treatment in vivo lead to 
the normalisation of cell functions of the AA rats due to the 
ability of these thiol compounds to react or interact with the 
various macrophage related inhibitory mechanisms discussed 
earlier.
Although in vivo D-penicillamine treatment can lead to 
normalisation of cell function it has no clinical effect on 
the disease development and severity of arthritic lesions of 
AA rats. The reason(s) are unclear. This may be due to D- 
penicillamine not being able to (1) inhibit leucocyte 
migration and hence subsequent proteolytic enzymes release, 
and (2) block synthesis of prostaglandins which are 
established mediators of inflammatory responses and have been 
long suspected to play an important role in articular 
destruction (Rainsford, 1982).
Alternatively, the development of AA may be due to viral 
infection since interferon (an anti-viral agent) inducing 
agents statalon (Kapusta and Mendenson, 1967), pyran copolymer 
(Kapusta and Mendenson, 1969), and tilorone (Chang and 
Hoffman, 1977) can inhibit AA. Virazole, an anti-viral agent 
which does not induce synthesis of interferon, will also 
inhibit AA. If this is the case, D-penicillamine cannot 
inactivate the virus or viruses that caused the AA and 
therefore has no effect on the clinical aspect of the disease.
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Before more convincing evidence is gathered the viral 
aetiology of AA must remain speculative.
Although D-pencillamine modifies the mononuclear cell 
functions in AA rats it has no effect on the clinical course 
of AA. The significance of altered mononuclear cell functions 
in the pathogenesis of AA is therefore questionable and the 
value of AA as a model for screening novel antirheumatic drugs 
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